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ABSTRACT 
For diabetics, continuous glucose monitoring, and the resulting tighter control of 
glucose levels, ameliorates serious complications from hypoglycemia and hyperglycemia. 
Today, diabetics measure their blood glucose levels multiple times a day by finger pricks, 
or use implantable monitoring devices. Still, glucose and other analytes in the blood 
fluctuate throughout the day and the current monitoring methods are invasive, 
immunogenic, and/or present biodegradation problems. Using carrier erythrocytes loaded 
with a fluorescent sensor, we seek to develop a biodegradable, efficient, and potentially 
cost effective method for long-term monitoring of blood analytes. We aim to reintroduce 
sensor-loaded erythrocytes to the bloodstream and conserve the erythrocytes lifetime of 
120 days in the circulatory system. 
Here, the efficiency of two loading procedures is compared. Hypotonic dilution 
employs hypotonic buffer to create transient pores in the erythrocyte membrane, allowing 
dye entrance and a hypertonic buffer to restore tonicity. Electroporation relies on 
controlled electrical pulses that results in reversible pores formation to allow cargo 
entrance. As part of the cellular characterization of loaded erythrocytes, size and 
hemoglobin content was evaluated. Cell recovery and fluorescence per cell measurements 
also render optimal loading conditions. Furthermore, AFM and confocal microscopy 
protocols were implemented to evaluate morphological changes induced by hypotonic 
dilution. The development of a suitable protocol to engineer carrier erythrocytes has 
profound and lasting implications in the erythrocytes’ lifespan and sensing capabilities.
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CHAPTER I  
INTRODUCTION 
In the United States, approximately 30 million people have diabetes and 87 million 
more have prediabetes. Thus, a third of the country’s population could become diabetics 
in the coming years [1,2]. Diabetes occurs when insulin insufficiency and/or cells 
unresponsive to insulin induce a rise of glucose levels in the blood. Irregular blood glucose 
level is a medical condition that requires accurate, continuous and long-term monitoring. 
Diabetics rely on the arduous task of maintaining normal glucose levels using costly, and 
complicated procedures. The regimen for most diabetics includes self-monitoring glucose 
levels multiple times a day using a fingerstick with a glucose meter, or an implantable 
continuous glucose monitoring system. Among other issues, common glucose meters’ 
accuracy are prone to human error, dependent on the meter and strip quality, and 
susceptible to interfering factors [3-6]. Longstanding concerns of implantable glucose 
monitoring devices are their immunogenicity and problems related to toxicity, selectivity 
and biodegradation [7-10]. Major complications arising from improper diabetes care 
include: blindness, renal disease, leg amputations and even death [11,12]. Furthermore, 
the lack of continuous glucose monitoring leaves diabetics vulnerable to complications 
such as hypoglycemia and hyperglycemia, which can lead to death. Diabetes incidence, 
prevalence, and mortality reveal the magnitude of the global burden and the need for a 
biocompatible, biodegradable, and potentially cost effective strategy to monitor 
continuously and for a long-term blood analytes. Erythrocytes loaded with a fluorescent 
analyte-sensitive dye (erythrosensors) can be detected using a light source through the 
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skin with the signal used for continuous monitoring of blood analytes, such as glucose 
[13-17].  
 
Glucose meters use electrochemical principles to measure blood glucose. Glucose 
oxidase converts glucose into glucolactone and oxygen into hydrogen peroxide. Clarke 
and Lyons first described an amperometric enzyme biosensor [18,19]. The enzyme 
electrode strip measures depletion or increase of reactant to indirectly correlate glucose 
concentration in a blood sample. Despite enzyme sensitivity and selectivity for glucose, 
difficulties arose pertaining operator errors which plagued the meter accuracy.  
 
Nowadays fingerstick-based glucose meters require a user to draw a blood sample 
by finger pricking, collect a blood drop on a sample strip, and read the glucose level 
measurement from a glucose meter [20,21]. The patient sparsely monitors blood glucose 
levels pre and post-prandial. Misuse of the glucose meter (improper calibration, poor 
blood sample, contamination etc.) and inadequate patient compliance disturb the accuracy 
of the glucose meter readings [22]. Moreover, sparse monitoring by finger pricking 
throughout the day, instead of continuous monitoring of glucose levels, hinders the 
construction of accurate trends and increases the risk of complications [3,4]. Continuous 
or near continuous measurements reduce the risk of serious complications resulting from 
either hypoglycemia (i.e. coma and death) or hyperglycemia (i.e. kidney failure, heart 
disease, gangrene, etc.) [23]. 
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The implementation of implantable continuous glucose meters (CGM) improve 
blood glucose levels monitoring and reduce the incidental hypoglycemia/hyperglycemia 
by providing real-time measurements. However this subcutaneously device also bear a 
new set of problems [24]. Both biochemical and cell-based devices have failed to address 
issues such as immunogenicity, intracutaneous reactivity, toxicity, selectivity and 
biodegradation [25,26]. Furthermore, current approved devices are limited to monitoring 
blood sugar levels for up to 7 days. Another drawback is susceptibility to malfunction due 
to patient physical activity and glucose level variability throughout the circulatory system 
[27,28]. A major concern lies on the fact that, over time, implantable continuous glucose 
devices tend to trigger an undesirable immune response; rapid recruitment of monocytes 
and macrophages signals the formation of a thick fibrotic capsule which physically and 
physiologically separates the device from blood vessels [29]. This separation can lead to 
inaccuracy and shortens lifetime. The lack of vasculature creates niches susceptible to 
infection, and variability in glucose level readings due to implant isolation [7,29,30]. 
Implantable glucose monitoring devices have improved self-monitoring of diabetes, but 
these devices’ long-term biocompatibility, and accuracy are still disputed [31-33]. 
 
Diabetes and other debilitating conditions can be diagnosed, treated and/or 
monitored by blood sampling. Blood testing stands as the most common procedure for 
health care. Because numerous medical conditions affect or are affected by the blood, it is 
the norm to use blood testing for the analysis of biochemical, toxicological and 
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immunological studies among others. Thus, the importance of exploring alternative long-
term blood monitoring.  
 
Given its public health importance, this work lays the foundations for the 
characterization of a novel alternative to manage diabetes. Diabetes self-management 
could change from multiple daily finger pricks to a doctor’s visit every three months to 
infuse erythrosensors, analyze trends, and implement a plan to manage the disease. It could 
also allow the prediction of events that significantly alter the glucose levels within the 
patient's habits. Circulating erythrosensors could help reduce or prevent complications by 
alerting patients of life-threatening events such as hypoglycemia and hyperglycemia [7]. 
A compelling benefit lies in erythrosensors’ ability to provide continuous data to assist 
physicians and patients in making better care decisions.  
 
Erythrocytes’ unique property of acting as a biocompatible carrier system can be 
exploited in biosensing [13]. Thanks to their circulation in the bloodstream, continuous 
monitoring could be achieved. The use of erythrocytes as an in-vivo biosensor dubbed 
erythrosensors, could improve diabetes care by reducing the burden of monitoring blood 
glucose throughout the day since carrier erythrocytes can circulate in the blood for up to 
three months [14]. Erythrosensors could address the need for an accurate, biocompatible, 
long-term blood-analyte monitoring platform. 
 
 
 5 
 
Erythrocytes 
In 1674, Lee Van Hock first described the microscopic characteristics of red blood 
cells also known as erythrocytes. The most abundant cells in humans, erythrocytes form 
in the bone marrow. One of blood’s major constituents along with plasma, white blood 
cells and platelets, erythrocytes’ primary job is to transport oxygen and carbon dioxide. 
Their characteristic biconcave-disc form maximizes their surface area for oxygen transport 
and exchange. However, these enucleated cells preserve key properties, such as size, 
volume and levels of hemoglobin, as they transit throughout the circulatory system. 
Erythrocytes navigate the circulatory system transporting molecules while maintaining 
their physiological properties. Having no internal organelles, erythrocytes rely on 
anaerobic glycolysis to generate energy. Erythrocytes’ ability to pull and squeeze through 
the circulatory system plays a key role in their life span. 
 
Mammalian erythrocytes maintain a constant volume despite severe deformation 
during circulation through capillaries. Bovine erythrocytes are approximately 5 µm in 
diameter, rat erythrocytes are approximately 6 µm in diameter and human erythrocytes are 
approximately 8 µm in diameter. However, the erythrocyte characteristic shape is flexible 
and the biconcave disk deforms to navigate through the smallest capillaries. These 
deformations depend of the diameter of the capillary and flow rate [34]. The “simple” 
architecture of erythrocytes is in fact a complex network of mechanical, chemical and 
biological interactions [16,35]  
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Aging cells display changes in size and morphology. These changes imply 
abnormalities in the cytoskeleton, membrane, motor/adhesive complexes and/or 
secondary reasons including precipitation of hemoglobin [36]. It is known that aging 
erythrocytes deform, often into spherocytes, and become more rigid, which interferes with 
their ability to circulate in the bloodstream. Ultimately, senescent erythrocytes are taken 
out of circulation via phagocytosis in the lymphoid organs. 
 
The erythrocyte membrane flexibility is dependent upon the cell cytoskeleton. A 
phospholipid bilayer, transmembrane proteins and membrane-associated proteins 
construct the erythrocyte membrane. The cytoskeleton is composed mainly of an intrinsic 
network of spectrin protein, which attaches to other transmembrane proteins [37]. These 
molecular interactions constitute the framework for the collective mechanical and 
chemical functions of the cell membrane and the cytoskeleton. The functions range from 
ion transportation across the membrane to cell-cell signaling. The cytoskeleton and cell 
membrane have a cooperative role in the behavior and properties of erythrocytes including 
the size and shape [36].  
 
Study of subcellular architecture has revealed difference between pathological and 
normal erythrocytes. Kamruzzahan et al. developed an anchoring technique to investigate 
erythrocytes shape from normal donors and patients suffering from systemic lupus 
erythematous (SLE) using atomic force microscopy (AFM). SLE is an autoimmune 
disease in which antibodies signal erythrocytes phagocytosis. Patients with SLE exhibit 
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spherical deformations, corrugations and holes in the erythrocyte morphology when 
compared to erythrocytes from healthy volunteers [38]. The resulting topographical 
images of immobilized and fixed human erythrocytes from healthy and disease patients 
showed morphological differences. This study described the immobilization of 
erythrocytes and produced AFM topographical images comparing healthy and 
pathological erythrocytes. 
 
Carrier erythrocytes and erythrocyte inspired delivery systems 
Known as pink, resealed, carrier and/or ghost erythrocytes/red blood cells, these 
cells form when native erythrocytes undergo osmotic, chemical, electrical, or 
reprogramming treatment and are loaded with exogenous cargo. There are a number of 
established methods to load erythrocytes with cargo, thus creating carrier erythrocytes. 
The hypotonic hemolysis technique relies on a hypotonic medium to drive the erythrocyte 
to a pre lysis point and load cargo [39]. Hypotonic dilution, is based on diluting 
erythrocytes in a lysis solution with the cargo to be entrapped [13]. Hypotonic dialysis is 
similar to hypotonic dilution, but it uses a dialysis tube filled with erythrocytes, and 
immersed in a hypotonic lysis solution to allow cargo to diffuse through the dialysis 
membrane for entrapment [40]. Stepwise hypotonic pre-swelling of erythrocytes in 
increasing hypotonic solutions to swell and allow cargo diffusion, is another method to 
load erythrocytes [41]. Erythrocytes can also be loaded using chemical perturbation 
through exposure to polygenic antibiotics [42]. In addition, loading of drugs/substances 
through electric break down or electroporation has been reported to open up pores with 
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diameters depending on the charge used, allowing cargo entry [43,44]. Recently, the use 
of erythrocyte membrane-derived erythrosensors as drug delivery vehicles and the 
genetically programming of erythroblast to express surface proteins in the erythrocyte 
membrane have been explored because of their biocompatibility and biodegradability 
[45]. 
 
A common method for preparation of carrier erythrocytes is via hypotonic dilution. 
Placing erythrocytes under hypotonic conditions swells the cells and leads to membrane 
poration. The regulation of internal and external molecules concentration allows the cargo 
to diffuse when reversible pores form and the cell attempts to equilibrate with the 
environment [13,14]. Restoring the homeostatic condition, reseals the pores encapsulating 
drugs, enzymes or molecules of interest, in this case a fluorescent dye.  
 
Fueled by the advances in loading procedures, there has been a steady 
implementation of carrier erythrocytes in the drug delivery field (Table 1). The use of 
erythrocytes to transport molecules began almost 50 years ago [16,46]. Carrier-
erythrocytes provide prolonged circulation, high encapsulation efficiency, and 
reticuloendothelial system (RES) targeting when compared with biomaterials for drug 
delivery [47-53]. Although, a carrier Erythrocyte system targeting RES is now in 
preclinical trails, a latent problem is maintaining the integrity of the properties that made 
erythrocytes attractive in the first place [50]. 
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Table 1. Suitable techniques to load cargo into erythrocytes 
 
Technique RBC Cargo Efficiency Ref. 
Hypotonic Hemolysis Human  FITC-dextran/FITC-Lysozyme  27–31% [54] 
Hypotonic Hemolysis Human  Antisense oligodeoxynucleotide 8-10% [55] 
Hypotonic Hemolysis Rat Bovine serum albumin 2% [56] 
Hypotonic Dilution Frog Taurine N/A [57] 
Hypotonic Dilution Human  Myo-[3H]-inositol 14% [58] 
Hypotonic dialysis Rat  Antiretroviral Zidovudine 30% [59] 
Hypotonic dialysis  Rat  Amikacin N/A [60] 
Hypotonic dialysis  Mice Etoposide 9.5% [61] 
Hypotonic dialysis  Mice   Glutamate dehydrogenase  56% [62] 
Hypotonic Pre-swelling Human  Interferon-α 2β 14.5% [63] 
Hypotonic Pre-swelling Human  Bovine serum albumin 30% [63]  
 
 
Carrier erythrocytes have also been studied for the transport of contrast agents and 
standards for imaging and cytometry applications. Doberstein et al. described erythrocytes 
loaded with dextran and rhodamine as standards for flow cytometry [64]. The finding 
suggests that the dextran-loaded erythrocytes had comparable fluorochrome content to that 
of commercially available microbeads for flow cytometry standards. Although, it is not 
clear if the fluorescent molecules were encapsulated in the erythrocytes or associated with 
the membrane. In recent years, there has been an increasing amount of literature on the 
application of nanoparticles-loaded erythrocytes for imaging. One study by Sungsook et 
al., examined the loading of gold nanoparticles (AuNPs) using the hypotonic dilution 
technique for dynamic x-ray imaging of blood flow. The results showed AuNPs aggregate 
with carrier erythrocytes to act as a contrast agent/flow tracer and enhance dynamic X-ray 
imaging [65]. To the best of our knowledge, the only work on AFM imaging of carrier 
erythrocytes was done to evaluate erythrocytes loaded with superparamagnetic iron oxide 
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nanoparticles (SPIONs) for MRI imaging [66]. Despite maintaining an average size, the 
topographical images of erythrocytes carrying SPIONS revealed a rugged surface. In 
addition, the height profile of the carrier erythrocyte reached around 70 nm and displayed 
collapsed membranes. Collectively, these studies outline the role of carrier erythrocytes 
in other biomedical applications. These studies also highlight the need to understand the 
physical properties of carrier erythrocytes. 
 
Despite the advantages of using carrier erythrocytes, little is known about how the 
physical properties contribute to prolonged circulation, slower drug release rate and 
eluding the immune system recognition. For instance, it has been reported that increased 
stiffness halts erythrocytes ability to squeeze through capillaries and can cause clogging 
[67]. Moreover, reports of carrier erythrocyte rapid clearance and phagocytosis have 
limited their implementation in other applications [41]. The membrane poration and the 
loss of hemoglobin during loading process, could lead to irreversible cellular changes, 
immune system recognition and premature clearance.  
 
Recent studies have raised concerns about the external adverse effects on 
transfused erythrocytes. Storage lesion, improper sample handling, and blood-borne 
diseases are a few of the challenges, the implementation of carrier erythrocytes face [68-
70]. Conserving erythrocytes physiological characteristics could improve the yield, 
integrity and the performance of carrier erythrocytes. 
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To address the limitations of carrier erythrocytes researchers are bridging the gap 
between synthetic and biological systems. A previous study reported nanoparticles linked 
to erythrocyte membranes [71-74]. Researchers found increased circulation time (up to 10 
hours) for in-vivo for nanoparticles non-covalently attached to the erythrocyte membrane, 
but it was feared that shear stress in capillaries could detach the nanoparticles from the 
erythrocyte in the long-term. A number of researchers have also reported biomimetic 
PLGA and PEG particles, which resemble erythrocyte morphology and function [72,74]. 
The biomimetic PLGA and PEG particles were engineered to have cellular properties 
similar to erythrocytes. The PLGA-RBCs displayed similar mechanical properties and 
oxygen-carrying capabilities while the PEG-RBCs rendered a tunable elasticity, which 
allowed them to circulate for a period of time similar to native erythrocytes [73]. To 
improve drug delivery, researchers used erythrocytes as nanoparticles transporters and 
created particles that mimic erythrocyte shape.  
 
Erythrosensors 
 Erythrocytes can transport a number of small molecules and biological agents, 
including sensing probes. Milanick et al. dubbed carrier erythrocytes (red cell ghosts) 
encapsulating an optical sensor, erythrosensors. Erythrosensors intend to provide long-
term and continuous measurements of extracellular analytes in the blood. After 
functionalization, erythrocytes carrying fluorescent sensors are transfused to the host 
animal or patient to monitor plasma analyte concentrations non-invasively via fluorescent 
detection. Conserving erythrocyte lifespan, erythrosensors could circulate in the 
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bloodstream for up to 120 days. The long-term goal is to automate the blood sampling, 
erythrocytes isolation, cargo loading, and erythrosensors resealing. One major drawback 
of this approach is that still requires a periodical blood sample, although not as often as 
using the fingerstick monitoring method for glucose, for example. 
 
To date, hypotonic dialysis and hypotonic dilution have been studied to generate 
erythrosensors. Both methods rely on an osmolarity change to cause membrane disruption. 
Hypotonic dialysis relies on a time-consuming diffusion exchange of higher osmolarity 
buffer to lower osmolarity buffer through a dialysis membrane and subsequently changing 
the osmolarity in the erythrocyte environment gradually. Hypotonic dilution is a method 
where erythrocytes are quickly diluted in a hypotonic buffer causing membrane lysis. 
Although both methods produced a number of fluorescent dye loaded erythrocytes 
(>50%), one major drawback has been that the resulting population had varying amount 
of dye loaded, and some resulting erythrosensors seem to have no dye loaded at all. 
Throughout this dissertation the terms non-uniform dye loading will be used to refer to the 
varying amount of dye loaded among a population of erythrosensors, where a portion of 
the erythrosensors appear to carry more dye than others. 
 
In a first study, sheep erythrocytes were subject to the hypotonic dialysis at 0°C, 
and subsequently washed and suspended in an isotonic solution to restore isotonic 
osmolarity. Fluorescence imaging revealed a loading efficiency >50% and non-uniformly 
dye loading among the population of erythrosensors [14]. Then, a theory to overcome 
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fluorescent detection of a non-uniformly dye loaded erythrosensors population was 
described, and a ratiometric approach for in-vivo work was recommended. 
 
An alternative loading process was then evaluated. Hypotonic dilution loading 
removes most of the hemoglobin of the erythrocyte. This method consists of placing 
erythrocytes in hypotonic solution at 0°C to create pores and quickly seal the membrane 
using a hypertonic buffer and 37°C incubation. The fluorescent micrographs revealed 
~50% loading efficiency, matching previous studies [13]. In addition, the emission 
spectrum of erythrosensors loaded with fluorescein isothiocyanate conjugated with 
glycylglycine (FITC-glygly) was shown to be equivalent to the emission by free FITC-
glygly. The most striking result from this study is the extracellular pH tracking by the 
erythrosensors loaded with a pH sensitive dye. The results demonstrated the idea that 
uniform dye loading is not required for pH sensing purposes [13]. However, neither carrier 
erythrocyte nor erythrosensor cellular properties are yet fully understood. 
 
A latent problem with erythrosensors lies in the innate heterogeneity of the initial 
erythrocyte population. Here the term heterogeneity is used to describe the different 
erythrocytes life cycles stages while in circulation (i.e. reticulocyte vs. mature 
erythrocytes). Reticulocyte mature into mature erythrocytes after 24-48 hours of entering 
the blood stream. Normal mature human erythrocytes live for approximately 120 days. 
Thus, not only is it necessary to consider the fate of aged erythrocytes, but also the fact 
that at any given moment the erythrocyte population of a blood sample contains 
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reticulocytes, and mature erythrocytes undergoing different cell cycle-related molecular 
modifications. Moreover, every second millions of new erythrocytes replace aged 
erythrocytes and will dilute erythrosensors in circulation [14]. In addition, physical 
activity, such as exercising, causes hypoxia to promote erythropoietin and subsequently 
erythrocyte production. This biological processes could impact the production of 
erythrosensors, and their circulation and sensing abilities. Using the 1-3% circulating 
reticulocytes to produce erythrosensors could address some of the issues related to the 
population heterogeneity; however, this work lies beyond the scope of this thesis. 
 
For long-term in-vivo sensing erythrosensors must first evade premature immune 
system recognition upon entering circulation. Ideally, after undergoing the loading 
process, erythrosensors would maintain the erythrocytes’ biochemical properties that 
signal self, such as the membrane protein CD47. Changes in the erythrocyte membrane’s 
integrity, flexibility and chemical composition would result in immune system detection 
and/or clearance in the spleen or by macrophages. However, erythrocyte membrane 
changes caused by loading procedures remain unknown. Furthermore carrier erythrocytes 
or erythrosensors cellular properties are not fully understood. 
 
This work focuses on four key features for optimal erythrosensor performance:  
hemoglobin content, size, morphology and uniform loading. Erythrocyte life span depends 
on a variety of physical properties. Erythrosensors must maintain near-normal hemoglobin 
level in order to preserve erythrocytes morphology, function within the circulatory system 
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and avoid immune system detection. Erythrocyte morphology is well understood. Thus, 
comparing erythrocyte and erythrosensor morphology could work as an indicator of 
viability. Albeit, theoretical work indicates that using non-uniform dye loaded 
erythrosensors does not alter the signal detection, uniform dye loaded erythrosensors not 
only simplifies the fluorescent signal detection but also efficiently exploits a donor’s 
erythrocyte sample [13].  
 
Chapter II introduces the methods used. Chapter III presents methods for 
erythrocyte loading with the model cargo fluorescent FITC-glygly that maximize the 
fluorescent signal. Dilution of erythrocytes in a hypotonic buffer and electroporation, 
application of small electrical charges to the erythrocyte, are evaluated [13,43,75,76]. 
While these loading procedures are used for drug delivery, this work combines loading a 
fluorescent dye as a sensor and using an erythrocyte as the sensor carrier.  
 
In pursuit of establishing reliable methodology to understand the physiological 
changes that erythrocytes undergo when converted into erythrosensors, non-uniform dye 
loaded erythrosensors produced via hypotonic dilution were explored. Different 
fluorescent dyes were used and morphological changes in erythrosensors were 
characterized. Two fundamental topics were investigated: the carrying capabilities and the 
cellular changes in erythrosensors made using the optimized hypotonic dilution procedure.  
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A procedure to uniformly load erythrocytes with fluorescent dyes while maintain 
intrinsic cell functions is essential for the survival of the erythrosensors in-vivo. In an 
effort to decrease recognition by the immune system, and achieve prolonged circulation 
time, chapter IV describes a simpler and faster swelling-based loading procedure. The 
FDA approved dye idocyanine green is studied for retinal imaging. The evaluation of 
erythrosensor population cellular properties pave the way for in vivo applications. 
 
The unique disk-like shape permits erythrocytes to squeeze throughout the 
circulatory system. For sensing applications, the fluorescent signal emitted through the 
complex physiology of the cell membrane, tissues and skin, pay a key role for detection. 
For erythrosensors to circulate in the blood stream undetected our goal is to maintain the 
intrinsic characteristics of erythrocytes, while maximizing the fluorescent signal intensity. 
Hypotonic dilution and a swelling method were evaluated to load erythrocytes with 
fluorescent FITC-glygly focusing on the size, shape and the fluorescent signal emitted by 
the FITC-glygly loaded erythrocytes. 
 
Final remarks in chapter V include a summary of the work, the limitations and 
outlook. The long-term goal is to optimize carrier erythrocytes with fluorescent dyes as 
continuous glucose erythrosensors. Creating a model system towards in-vivo cell-based 
sensing, to avoid conventional glucose meters and/or blood sampling: an adaptable 
technology for long-term monitoring which can avoid the sentinel cells of the human 
immune system.  
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CHAPTER II 
METHODS 
The focus of this work was to investigate changes to key erythrocyte properties 
after loading, optimize alternative procedures, and generate uniformly loaded 
erythrocytes. Rat blood samples were collected into CDPA anticoagulant. Whole blood 
samples were centrifuged at 12,000 ×g for 5 minutes, and the plasma and white blood cells 
were removed. The cells were washed with 165 mM NaCl. Bovine blood was collected 
into CDPA anticoagulant and gentamicin container and washed before procedures. 
Fluorescent fluorescein isothiocyanate (FITC), as model cargo, was obtained from Sigma 
Aldrich (46950 Sigma). Two widely used loading protocols were explored for loading 
erythrocytes: electroporation and hypotonic dilution. Both methods create pores in the cell 
membrane to allow cargo entrance, and use a 37° C incubation and a buffer to restore the 
cell membrane [13,14,42]. However, electroporation relies on electrical charges, while 
hypotonic dilution makes use of a hypotonic buffer to create the reversible pores. A 
preswelling method was develop, towards maintaining the erythrocyte cellular properties.  
 
Electroporation 
The temperature of packed erythrocytes was lowered to 0° C. Electroporation 0.2 
cm cuvettes for 400 μl samples were used. Electroporation was performed using a Bio-rad 
Gene Pulser Xcell™ system at 250, 300 and 750 V with a square wave pulse ranging from 
0.5 to 5 ms, and intervals of 15 minutes for a total of four cycles. Cells were incubated for 
10 minutes at 4° C, and diluted 1:2 in resealing solution consisting of 8 mM KCL (P9541-
 18 
 
Sigma), 150 mM NaCl (s9888-Sigma), 6 mM NaH2PO4 (s5011-Sigma), 10 mM D-
Glucose (g8270-Sigma), 2 mM magnesium chloride (MgCl2 M8266-Sigma), 1% BSA, 
pH 7.4. Resealing was achieved by incubation at 37°C for 1 hour and at 4°C for 24 hours. 
Loaded erythrocytes were washed with phosphate buffer saline (PBS) by centrifugation 
and stored at 50% hematocrit in ice (4°C) [43,75,76]. Control cell for the experiment were 
electroporated at 300 V amplitude and 1 ms pulse width to account for possible auto 
fluorescence. In addition, a second control was prepared using naive erythrocytes at the 
same concentration as the samples electroporated, and placed in a cuvette with FITC-
glygly but the samples were not electroporated. This control was used to determine 
spontaneous uptake of the fluorescent dye, if any.  
 
Hypotonic dilution  
The temperature of hypotonic lysis buffer (10x solution consisting of 10 mM 
MgCl2, 20 mM EDTA, 50 mM phosphate buffer, 1 mM Urea) was lowered to 0-2° C and 
1 ml FITC-glygly at pH 9.0 was mixed in 25 ml of 1x hypotonic lysis buffer (2.5ml of the 
10X lysis buffer +22.5 ml deionized water). Packed erythrocytes (2 ml) were diluted in 25 
ml aqueous lysis solution and incubated for 10 minutes. Then 2.5 ml of concentrated 
hypertonic lysis buffer (10x) were added followed by incubation for 10 minutes at 0° C, 
and then at 37° C for 30 minutes. Looking to achieve a more uniform loading, cells were 
gently shaken every 10 minutes for the duration of the incubation. The resultant mixture 
was then centrifuged; the supernatant saved for absorbance measurement, and the pellet 
centrifuge with 165 mM NaCl (washing solution) until supernatant was visible clear. To 
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eliminate FITC-glygly and debri aggregates, the sample was passed through a 40 µm 
membrane and suspended at 50% hematocrit (hct) in PBS. 
 
Preswelling 
Bovine whole blood in CDA anticoagulant was rinsed with Phosphate buffer 
solution (PBS) and the top layer of white blood cells was removed. Packed erythrocytes 
(1 ml) were resuspended in 1 ml of preswelling buffer, and incubated for 3-5 minutes to 
allow pore formation while mixing gently by inversion. FITC-glygly (5 mM FITC mixed 
with 20 mM glygly for 30 minute at room temperature) or ICG cargo was added and the 
cells were incubated for additional 5 minutes, followed by the addition of resealing 
solution (1.65 M KCl, 0.2 M NaCl, 33 mM NaH2PO4, 0.1 M Glucose, 4 mM MgCl2, 1 
mM Inosine, 1 mM Adenine). The sample was incubated at 37° C for 1 hour. Finally the 
samples was centrifuged (5-7x) at 745g for 3 minute with PBS and suspended at 50% hct 
(v/v) in PBS. 
 
Fluorescence microscopy 
Following encapsulation, samples were immediately imaged using a Nikon TE 
2000 Epi-fluorescent microscope. Nikon Blue excitation block B-2E/C was used to excite 
FITC, which absorbs at 492 nm. A 5 µl sample was taken from the 50% hct sample and 
deposited on a microscope slide and smeared/covered with a 0.15 mm coverslip for 
imaging. The corrected total cell fluorescence (CTCF) was determined using randomly 
selected cells from each group (Electroporation 300 V and hypotonic dilution). The 
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average integrated density, area, and mean fluorescence background signal was used in 
the following equation: 
 
CTCF = Integrated density – ([Area of cell] X [Mean fluorescence of 
background]) 
 
Spectrophotometry 
Hemoglobin and FITC-glygly concentrations were determined using the Hitachi 
U-4100 UV-Vis-NIR spectrophotometer. The absorbance of hemoglobin in the 
supernatant was measured at 540 nm, and the absorbance for FITC was measured at 492 
nm using the liquid stage. Similarly, the theoretical amount inside the erythrocytes was 
calculated using 100 µl samples of control erythrocytes, 100 µl of FITC-glygly cells 
loaded via electroporation and 100 µl of FITC-glygly cell loaded via hypotonic dilution. 
Samples were lysed with 900 µl deionized water (diH2O). Absorbance measurements were 
recorded on the same day. Using as reference the fact that hemoglobin concentration in 
bovine blood ranges is 8-15 g/dl, the concentration inside control erythrocytes was 
calculated. Hemoglobin retained after loading was calculated using the absorbance at 540 
nm of lysed samples. The resulting absorbance was multiplied by the dilution factor, and 
subsequently multiplied by the factor relating concentration and absorbance (cell 
concentration found divided by the absorbance obtained).  
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Confocal microscopy 
Cells were fixed in 0.025% glutaraldehyde to increase mechanical strength and 
stability. Then a 5 µl sample was deposited on a Poly-L-Lysine (PLL) coated slide to 
immobilize the sample for imaging. Confocal fluorescence microscopy was performed 
using an Olympus FV1000 confocal microscope. A 100x objective with a 1.4 numerical 
aperture was used to image the fluorescence emission under 488 nm (Argon) laser 
excitation. Stacking in the Z-axis direction of the fluorescence images was accomplished 
by capturing optical slices at 0.37-0.45 µm intervals through the sample sequentially. 
Fluorescence was collected using a 505–575 nm filter set. Analysis and reconstruction of 
3D volumetric images was achieved using the full version of Olympus confocal software. 
For the work creating z-stack of bovine and human erythrocytes after preswelling loading 
in chapter III, the Zeiss Laser Scanning Microscope (LSM) model 710 equipped with a 
40X/1.3 oil objective and Zen 2010 software was used. ImageJ was used for image 
analysis.  
 
Atomic force microscopy 
To produce AFM topographical images of erythrosensors and naive erythrocytes, 
cells were fixed using 0.025% glutaraldehyde, and deposited on a Poly-L-Lysine (PLL) 
coated slide. The Bruker Dimension Icon AFM was used for scanning and obtaining 
topographical image from erythrosensors and naive erythrocytes. Ideally, when imaging 
cellular samples, a spherical AFM tip should be used. Because of time/funding constrains, 
we used a diamond tapping tip and the ScanAsyst in tapping mode to image the sample. 
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The scan size was 40 µm x 40 µm, the rate was 0.500Hz, and there were 512 samples/line. 
For the tapping mode, the Bruker tip MPP21000 RSFP 3N/m was used. 
 
 Contact mode measures topography and lateral force image/friction by scanning 
the probes in a raster patter on the sample surface, while monitoring the cantilever 
deflection. Tapping Mode refers to the oscillation of the probe near its resonance 
frequency and intermittently interaction with the sample surface. PeakForce Tapping is a 
company-developed mode where the cantilever oscillation (below resonance), results in 
sequential force-distance curves. ScanAsyst is an image-optimization scanning mode and 
works similar to PeakForce Tapping. Using ScanAsyst, the system continuously monitors 
image quality and makes parameters adjustments to parameters such as set point, feedback 
gain, and scan rate. This mode operates at lower forces than tapping mode, and uses the 
force curves as an imaging feedback signal.  Erythrocytes are delicate samples; hence, a 
combination of ScanAsyst (liquid) and tapping mode (air) was used for AFM experiments 
to minimize force applied to the sample.  
 
 To quantify the surface roughness, the mean of the absolute vertical deviation from 
the mean line of the topographical profile, Ra, was calculated. Briefly, a 1 µm x 1 µm 
section was chosen from six different topographical images (three control RBC images 
and three erythrosensors images). From each cell three Ra values were calculated and 
averaged using the Nanoscope software version 6.14. 
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Image flow cytometry 
For each sample, 20,000 images were collected. The template of the image flow 
cytometer to acquire the data, relies in calibration beads to focus the laser and to monitor 
the flow rate. The cell classifier function was used to avoid debris and target cells based 
on size. The 488nm laser power was set to 20 mW. Subsequently, the IDEAS Version 4.0 
image analysis software package (Amnis) was used to analyze the data. Morphologic 
(circularity, and aspect ratio), dimension (area, and length,) and fluoresce intensity 
parameters of erythrocytes and erythrosensors loaded via the optimized hypotonic dilution 
or the swelling procedure were calculated using images of erythrocytes by IDEAS 
software. 
 
Statistical analysis 
One-way ANOVA and t tests were performed using GraphPad Prism Software 
version 6.00, La Jolla California, USA. The image flow cytometry data was interpreted 
using principal component analysis (PCA). PCA approximate visualization of the dataset 
by reducing the dimensionality of complex data. The dimension, morphological and 
fluorescent features were analyzed using SAS. 
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CHAPTER III 
HYPOTHONIC DILUTION VS ELECTROPORATION  
This study offers insight into maximizing loading of FITC-glygly into erythrocytes 
by optimizing and implementing loading protocols. Erythrocyte life span depends on a 
variety of properties including cell size, volume, shape, surface electrical charge, and 
stiffness. This chapter focuses on comparing loading efficiency, hemoglobin contents and 
fluorescent signal of two different loading procedures: hypotonic dilution and 
electroporation (Figure 1). 
The goal is to evaluate alternative loading procedures and minimizing changes to 
the erythrocyte morphology while achieving uniform dye loading using hypotonic dilution 
and/or electroporation. Conserving the innate erythrocyte properties in erythrosensors is a 
concern for erythrocyte-based sensors. Thus, questions have been raised about 
erythrosensors’ ability to survive for prolonged biosensing based on changes to the innate 
erythrocyte structure. To investigate hemoglobin preservation and loading efficiency, data 
was drawn from two main sources: fluorescence microscopy imaging and 
spectrophotometry. Both hemoglobin preservation and loading efficiency must be taken 
into account for creating erythrosensors. Changes in hemoglobin concentration were 
 Part of the data in this chapter is reprinted with permission from “Characterization of 
carrier erythrocytes for biosensing applications” Bustamante López SC, Meissner KE, 
2017. Journal of Biomedical Optics, 0001; 22(9):091510, Copyright 2017 by Society of 
Photo-Optical Instrumentation Engineers. 
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analyzed using spectrophotometry for erythrocytes loaded via both, electroporation and 
hypotonic dilution. Statistical analysis was used to show significant differences between 
the concentration of hemoglobin of erythrosensors loaded via hypotonic dilution and 
electroporation. Confocal microscopy and AFM were used to understand erythrosensor 
size, morphology and uniformity of the dye loaded. 
 
 
Figure 1. Electroporation vs. hypotonic dilution procedures.  
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Electroporation relies on short but intense electrical charges to create trans-
membrane pores and allow cargo entrance [43,75,78]. Due to the membrane potential 
difference and reversible electric breakdown, the membrane phospholipid reassembles 
forming hydrophilic pores. This technique has achieved popularity for drug delivery and 
transformation/transfection applications because the pore size is tunable and dependable 
on the electroporation conditions. Proteins, nucleic acids, and particles have been 
encapsulated via electroporation [44,79,80]. The standard parameters for human 
erythrocyte loading are 300 V, 1 ms pulse time and up to 8 pulses every 15 minutes. The 
membrane poration is then resealed by incubation at 37°C [43]. Under optimal conditions, 
erythrocytes loaded using this technique have high cell recovery. In addition, the cells 
maintain their size and shape, and in vivo circulation times [75]. These attributes motivated 
the evaluation of electroporated erythrocytes for use as erythrosensors. The efficiency of 
this technique to load FITC-glygly into erythrocytes was evaluated under different 
conditions. 
 
Hypotonic dilution, as indicated by the name, consists of the dilution of 
erythrocytes in a mix of hypotonic buffer plus the molecule to be encapsulated. This 
change in osmolarity creates pores or lyses the erythrocyte membrane, depending on the 
osmolarity, and allows cargo entrapment as erythrocytes attempt to equilibrate with the 
extracellular environment, in a homeostatic process [81,82]. Since erythrocytes lack 
mechanisms of volume control, they swell as consequence of the ion channels and 
transporters in the membrane that allow water permeability [83]. These membrane pores 
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also allow large molecules, such as FITC-glygly, to diffuse, thanks to the concentration 
gradient. Pore lifetimes are temperature dependent and the process is reversible. The 
osmotic equilibrium is restored with hypertonic buffer and resealing is achieved by 
incubation at 37°C. A number of procedures based on hypotonic swelling, but hypotonic 
dilution has remained the simplest and fastest. 
 
A major challenge of using erythrocytes as fluorescent dye carriers is how to entrap 
the cargo without compromising the erythrocyte integrity. For the electroporation 
procedure, a number of parameter were studied. The temperature prior to electroporation 
was lowered to 0-4°C, aiming to expand the lifetime of the transient pores formed. The 
erythrocytes were re-suspended in a formulated electroporation buffer during the 
procedure with the intent of improving efficiency and minimizing erythrocyte cellular 
modification.  Post electroporation erythrocytes resealing, temperature and incubation 
parameters were investigated for recovery. For the hypotonic dilution procedure, looking 
to increase loading efficiency and generate uniformly loaded erythrocytes, mixing 
throughout the procedure and an extra centrifugation step to concentrate the loaded 
erythrosensors were studied. The extent of the limitations associated with these procedures 
include low encapsulation efficiency, non-uniform dye loading and loss of hemoglobin, 
which affects intrinsic cellular functions [13,40,62,84]. 
 
Bovine erythrocytes were used in lieu of human erythrocytes. Erythrocytes were 
loaded using established protocols for both procedures. Smaller than human erythrocytes, 
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bovine erythrocytes have a diameter of 5 µm. In addition, human and bovine erythrocytes 
have different membrane phospholipids and protein arrangement. Zimmerman et al. 
(1982), showed data indicating that, although bovine erythrocytes are smaller, a higher 
field strength electroporation is required, compared to human erythrocytes electroporation 
response [85,86]. It has also been reported that, although after electroporation the pore 
size doesn’t seem different, the leak permeability, defined as the measurement of tracer 
fluxes, differs. At 0°C the pores are stable and increasing the temperature rapidly reseals 
the membrane [75,87,88]. Another important difference between human and bovine 
erythrocytes, is that the bovine erythrocyte lifespan is around 160 days.  
 
Confocal microscopy has been used to study the distribution of FITC-labeled BSA, 
and other molecules within carrier erythrocytes in drug delivery [84]. However, little is 
known about the cargo location, external or internal. In this study, we compare the 
fluorescence of loaded erythrocytes with that of “empty” carrier erythrocytes and control 
erythrocytes. To verify volume-loading capacity, z-stack confocal images were analyzed. 
To explore species independence, both rat and bovine erythrocytes were evaluated for 
loading uniformity, and morphology.  
 
Using AFM, the topography and shape of carrier erythrocytes was studied. AFM 
allowed semi-destructive imaging since the cells were fixed. High-resolution topography 
reveals details at the subcellular level. Furthermore, different AFM modes can be used to 
control the nano-stimulation and investigate the physiological properties of erythrocytes. 
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To understand the morphological changes in erythrocytes loaded using the hypotonic 
dilution technique, AFM was used to evaluate the topography of the resulting 
erythrosensors. 
 
Results 
The electroporation and hypotonic dilution parameters were optimized, but first 
the FITC-glygly conjugation reaction was evaluated via HPLC to ensure the correct 
stoichiometry. A molar ratio FITC to glycylglycine of 1:4 at pH 8.0-9.0 was found to 
provide the highest ratio relative peak heights between unreacted FITC and conjugation 
product (Figure 2). Different molar ratios of FITC to glycylglycine were evaluated: the 
4:1 ratio was found to have a peak height ratio of 1:20, the 1:1 ration was found to have a 
peak height ratio of 1:2 and the 1:4 ratio was found to have a 37:4 peak height ratio. Thus, 
showing that the FITC to glycylglycine reaction at a molar ratio of 1:4, reveal a higher 
peak height ratio indicative of increased conjugation of FITC-glygly and less unreactive 
reactants. 
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. 
Figure 2. FITC-glygly conjugation verified by HPLC. A reference standard solution 
was used for reactant FITC identification.  FITC-glygly at a molar ratio 1:4 had the 
highest peak height ratio. 
 
 
To investigate the conditions for FITC-glygly erythrocyte loading via 
electroporation, the voltage amplitude effect on the erythrocyte diameter size were 
compared. Then the fluorescent signal at different amplitudes was evaluated. 
Electroporation was performed at various amplitudes to optimize cell survival and loading. 
The effects of electroporation at different amplitudes on the diameter of the carrier 
erythrocyte were assessed and compared with the diameter findings of the native 
erythrocytes. In addition, the fluorescence per cell was evaluated as a measurement of 
loading efficiency at the respective amplitude. 
Conjugate 
Unreacted 
FITC-glygly 1:4 Molar ratio 
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As an initial assessment, the size of the erythrosensors generated via the 
electroporation procedure were compared with control erythrocytes. Normal bovine 
erythrocyte diameter measure 5.5 - 5.8 µm in diameter [89,90]. The control erythrocytes 
were found to have a diameter mean of 4.896 µm +/- 0.297 standard deviation, which lies 
below the normal erythrocyte diameter. Erythrosensors diameter electroporated at 200 V 
and 300 V, exhibit not significant, ns (p > 0.05) difference to the erythrocytes diameter of 
the control cells. A slightly smaller average diameter for the cells (except by cell 
electroporated at 750 V or more) was retained (Figure 3). The cell size of the control cells 
and experimental samples was found to be around 5 µm. When compared to the control 
cells, the bright field images reveal similar size. Cells electroporated at 200 V were found 
to have an average size of 4.37 µm, cell electroporated at 300 V had an average size of 
5.32 µm, and cells electroporated at 750 V had an average size of 5.73 µm.  Cells 
electroporated at 750 V had the largest diameter size, and also the greatest variation 
between size, which can account for erythrocytes swollen, lysed, and debris fragments. 
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Figure 3. Average erythrocyte size for electroporated cells at different amplitudes. 
Error bar represent the standard deviation. The symbol ns indicates p >0.05.  
 
 
As shown in fluorescence micrographs and corrected total cell florescence chart, 
samples electroporated at 300 V seem to have significantly more FITC-glygly 
fluorescence per cell than the other samples (Figure 4). Overall, electroporated 
erythrocytes had the most fluorescence per cell at 300 V amplitude and 1 ms pulse width. 
At 200 V at 1 ms, it was found that the cells had approximately half the fluorescence per 
cell as the erythrocytes electroporated at 300 V. Cells electroporated at 200 V most likely 
did not load as well because the size of the pore is dependent on the amplitude applied. 
 
The average corrected total cell fluorescence (CTCF) at 300 volts was found to be 
the highest among the samples evaluated. For the 300 V electroporated erythrocytes CTCF 
the outlier fluorescence on the image was omitted from the data (Figure 4). This outlier is 
most likely a FITC-glygly aggregate. Control erythrocytes exhibit no florescence as 
 33 
 
expected, indicating no auto fluorescence associated with cells. Erythrocyte electroporated 
at 200 V and 1 ms pulse width exhibit lower fluorescence per cell than the erythrocytes 
loaded using amplitude of 300 V and the same pulse width. The samples electroporated at 
750 V had the least fluorescence detected, probably due to the irreversible break down of 
cells, lead to complete hemolysis and a mix of FITC-glygly and erythrocyte debris. 
 
Electrical hemolysis of bovine erythrocytes was also observed. The resulting 
micrographs show erythrocyte lysis/death at 750 V. The cells electroporated at 750 V and 
above exhibited increased cell death and debris as amplitude increased (data shown for 
750 V only).  At 750 V, cell rupture due to the irreversible breakdown is shown. Cell 
debris, and fewer cells are observed in the micrographs. This indicates that threshold value 
of the electric field was at or above what Erythrocyte membrane could withstand. 
 
The characteristic morphology of erythrocytes is not evident from the 
micrographs. Only the circular outline is seen in the micrographs.  The control and the 300 
V electroporated erythrocytes have the distinct ring shaped contour. However, the contour 
of the cells electroporated at 200 V is obscured by the brightness of the image. At 750 V, 
there are only sporadic cell outlines discernible, with irregular contours. 
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Figure 4. Erythrocytes electroporated at different amplitudes. Top: Fluorescent 
micrograph. Bottom: Relative cell fluorescent at different amplitudes. The symbol 
ns indicates p >0.05. 
 
 
The absorbance curve for hemoglobin release into the supernatant shows the 
presence of both hemoglobin and FITC (Figure 5). Hemoglobin release was diminished 
with the use of electroporation buffer. Hemolysis was evident in samples electroporated 
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at 400 V and higher. Further analysis was done to compare with the release of cells loaded 
via hypotonic dilution. At 200 V and 300 V there was a similar curve (shown below). The 
hemoglobin sample correspond to the normal release of a control erythrocyte sample at 
4°C. Absorbance curves of supernatant after electroporation revealed a FITC related peak 
at 492 nm and hemoglobin related peaks at 540 nm and 575 nm. 
 
 
 
Figure 5. Electroporation: Absorbance curve of hemoglobin released in supernatant. 
Spectra curve of supernatant showing hemoglobin released from naive erythrocytes 
(hemoglobin), FITC-glygly (FITC) and carrier erythrocytes loaded by 
electroporation at two different amplitudes (200 V and 300 V). 
 
 
To assess the optimal pulse width, cells were stimulated at 300 V, with pulse 
widths of 0.5 ms, 1 ms, or 5 ms every 15 minutes through four cycles.  The square wave 
pulse used for this experiment maintains a constant level during the length of the pulse.  
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Control cells were electroporated using the longest pulse time, 5 ms. Erythrocytes 
electroporated at 300V using a pulse width of 1 ms had a significant amount of 
fluorescence detected by fluorescence microscopy. Thus, varying pulse length and the 
constant 300V amplitude was studied to identify the ideal conditions for loading FITC-
glygly into bovine erythrocytes (Figure 10). 
 
The fluorescence of erythrocytes loaded via electroporation using different pulse 
widths was shown in figure 6. A trend of increasing cell fluorescence with decreasing 
pulse length was revealed. Control erythrocytes exhibit no auto fluorescence. Bright field 
micrographs show similar Erythrocyte population. The fluorescent micrographs hint that 
the erythrocytes which were pulsed for 0.5 ms with 300 V, showed the most fluorescent 
per cell. As can be seen from the corrected total cell fluorescence for this sample indeed 
the 0.5 ms pulse length attained the highest levels of fluorescence per cell. The 
erythrocytes electroporated with a pulse length of 1 ms, had lower fluorescent per cell, 
while the erythrocytes electroporated by 5 ms exhibit the lowest fluorescence per cell. 
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Figure 6. Bovine erythrocytes loaded via electroporation. A voltage of 300V and 
different pulse widths were used. Bright field images (top) and fluorescent 
micrograph (bottom) are shown. The fluorescent per cell revealed at different pulse 
widths.  
 
 
Turning to the experimental evidence on loading erythrocytes using the hypotonic 
dilution method. Figure 10 shows that cell loaded efficiently. To characterize the loading 
efficiency and visualize the loaded-RBCs, fluorescence from FITC was detected using 
fluorescent microscopy. Following the use of FITC-glygly at pH 9.0 and the gentle mixing 
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of cells every 10 minutes during the incubation at 37°C, an increase in cell loading was 
noted. 
 
From the 20X fluorescent and bright field micrograph it is difficult to describe if 
the cells maintain their biconcave shape (Figure 10). However, the cells appear as circular 
erythrosensors in the bright field micrographs. By means of fluorescence microscopy, it 
was observed that the fluorescence of the cells seems higher than using electroporation. 
Photobleaching was observed after 2 seconds imaging, which could interfere with the 
fluorescence signal detected in our results as shown in the images below. 
 
 
 
Figure 7. Erythrocyte loaded with FITC-glygly via hypotonic dilution. (Top) Bright 
field images of “ghost” erythrocytes and fluorescent images of three experiments D1, 
D2 and D3 (Middle). Right-bottom image of photo bleaching after 2 seconds exposure 
(D3) 
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The recordings of the absorbance of the supernatant on the spectrophotometer are 
comparable to the readings of electroporated cells (Figures 5 and 8). The absorbance 
measurements of the supernatant shows the presence of both hemoglobin and FITC 
(Figure 8). The hemoglobin sample corresponds to the normal release of a control 
erythrocyte sample at 4°C and the absorbance peaks are shown at 540 nm and 575 nm. 
Absorbance curves of supernatant after hypotonic dilution also revealed a FITC related 
peak at 492 nm. The absorbance spectrum corresponds to diluted samples (Hg1 and Hg2), 
taken from two representative experiments. 
 
 
 
Figure 8. Hypotonic dilution: absorbance curve of hemoglobin released in 
supernatant. Spectra curve of supernatant showing hemoglobin released naive 
erythrocytes (hemoglobin), and hypotonic dilution erythrosensors (D1 and D2) 
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Looking at the concentration of hemoglobin inside the erythrocytes loaded via 
electroporation, the erythrocytes maintained significantly higher levels of hemoglobin 
than the cells loaded using hypotonic dilution. The three samples of different experiments, 
control, hypotonic dilution erythrosensors and electroporation erythrosensors, were 
evaluated and compared for hemoglobin content (Figure 9). 
 
Normal bovine erythrocytes contain between 8-15 g/dL hemoglobin [39,89]. The 
hemoglobin in the control sample was estimated to be between 8.808 +/- 1.409 g/dL, 
which stands in the lower range of the normal bovine erythrocyte hemoglobin 
concentration. This may be due to handling and process, or spontaneous leakage of 
hemoglobin throughout the experiment. Overall, this is a good standard control, which 
correlates well with the literature. 
 
The figure 9 shows that cells loaded using hypotonic dilution lost the most 
hemoglobin through the loading process. The concentration of hemoglobin inside the 
erythrosensors loaded using hypotonic dilution was found to be in the range of 1.004 +/- 
0.559 g/dL. This is in accordance with the results showing a significant amount of 
hemoglobin in the supernatant after loading. The cells lost approximately 89% of their 
initial hemoglobin content. Losing this much hemoglobin will be a challenge for the 
survival of erythrosensors produced using the hypotonic dilution technique. The average 
hemoglobin concentration inside cell loaded via electroporation was approximately 5.632 
+/- 0.589 g/dL. On average, electroporated erythrocytes lost approximately 46% of the 
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total hemoglobin. As shown in figure 9, erythrosensors created using electroporation 
retained higher concentrations of hemoglobin. 
 
 
 
Figure 9. Diameter, and hemoglobin content of erythrosensors. Absorbance at 
540nm of lyse control erythrocytes and erythrosensors prepared using the hypotonic 
dilution and electroporation procedure. 
 
 
The CTCF was used as a measurement of fluorescence intensity per cell in the 
sample (Figure 10). The average CTCF of the cells in the micrograph was calculated 
using Image J software to segment 4 images per condition. A total number between 100-
150 cells were evaluated for each procedure. The results of erythrocytes loaded via 
hypotonic dilution were compared to those of cells loaded using electroporation. The 
difference in cell fluorescence intensity between samples was evident from the 
micrographs. This quantification was applied to uniform samples; ten randomly chosen 
cells for each micrograph were evaluated. The results revealed that cells loaded through 
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hypotonic dilution, had four times more fluorescence intensity than cells loaded using 
electroporation. 
 
 
 
Figure 10. Cell fluorescence as a measure of loading efficiency. Corrected total cell 
fluorescence of ten randomly chosen cells from a 20X micrograph representative of 
cell loaded by electroporation or hypotonic dilution. Cell’s integrated density, Area 
and the mean fluorescence of the background were used to evaluate the average 
fluorescence signal per cell. * P ≤ 0.05 
 
 
Confocal microscopy and AFM were used to evaluate key cellular features in the 
erythrosensors. Confocal fluorescent micrographs show different loading levels among a 
sample and further processing was established to concentrate cells with similar loading 
efficiency. AFM revealed changes in the topography, and stability of the cell and its 
membrane. In addition, both procedures were used to evaluate the size and morphology of 
erythrosensors. The resulting images show strong evidence that erythrosensors loaded via 
hypotonic dilution are damaged; this could impact erythrosensors in vivo lifespan. 
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Figure 11. Confocal micrographs of control carrier erythrocytes and erythrosensors. 
Control1: native erythrocytes. Control2: Auto fluorescence control, erythrocytes 
were subject to hypotonic dilution without FITC-glygly. 
 
 
Confocal micrographs obtained from two controls and a sample of bovine 
erythrocytes loaded via hypotonic dilution provides a close look at the different 
erythrosensor formation and the mixed loading efficiency (Figure 11). The control1 show 
native erythrocytes which were subjected to the same temperature and centrifugation 
condition as the experimental samples. The control1 erythrocytes exhibit the distinctive 
shape of normal erythrocytes. To show that the fluorescence detected is associated with 
loading of FITC-glygly and not an artifact of auto fluorescence, the second column of 
micrographs shown in figure 11, presents images from native erythrocytes loaded via 
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hypotonic dilution with no FITC-glygly and resulting in membranes without fluorescence 
(control2). The dilution process to load FITC-glygly on experimental samples was carried 
out as before; the samples showed a non-uniform dye loaded population of erythrocytes 
with approximately 30% exhibiting fluorescence, while different erythrosensors in the 
micrograph exhibit varying levels of fluorescence. 
 
 
 
Figure 12. Separation of cargo loaded erythrosensors. Cell were separated by 
centrifugation. 
 
 
The results obtained from the preliminary analysis of confocal images of 
erythrosensors loaded via hypotonic dilution, are shown in Figure 12. It is apparent that 
fully loaded cells are diluted within unloaded cells. To concentrate loaded and unloaded 
cells by density, centrifugation for 5 minutes at 10000 g was used. The samples layers 
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were imaged, revealing highly loaded cells at the bottom (Figure 12). For standardizing 
the methods to evaluate fully loaded erythrosensors, this centrifugation process was used 
for the remaining of the experiments. 
 
 
 
Figure 13. Z-Stack of erythrosensors entrapping different cargo. FITC-glygly, 
TRITC and Rhodamine 6G were used. A. Representative maximum intensity 
projection for each cargo. B. z-stack with step size between images shown is 45 µm.  
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Figure 14. Loading different dyes using hypotonic dilution. Analysis of dye 
internalization shows the standard deviation differences and mean value. FITC-
glygly exhibit more variance on the loading, while RITC-dextran (commercial dye) 
load more homogeneously through all the erythrosensors. Rhodamine 6G, show not 
internalization at all.  
 
 
Z-stack micrographs of erythrosensors revealed non-uniform FITC-glygly loading 
within the erythrosensor (Figure 13 and Figure 14). Fluorescent images show the 
fluorescence of FITC-glygly through the erythrosensors. So far FITC-glygly has been used 
to study erythrosensors, a question about if the loading efficiency was perhaps fluorescent 
dye dependent emerged. The fluorescent dye chemistry could play an important role 
throughout the loading procedure. To compare the loading entrapment efficiency, the 
same hypotonic dilution procedure using different dyes was performed. A dextran labeled 
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with rhodamine B isothiocyanate (TRITC), used in drug delivery studies and a lipophilic 
probe commonly used to study membrane transport were evaluated. The cell recovery 
calculated as the ratio of the resulting erythrosensors packed volume to the initial packed 
erythrocytes volume, remained the same for the three dyes, around 10%. After isolation, 
80% of erythrosensors loaded via hypotonic dilution using FITC-glygly had some 
entrapment, compare to >98% when using TRITC. As expected Rhodamine 6G seems to 
associate with the cell membrane thus leaving a hollow non-fluorescent space inside the 
cell, demonstrating the fluorescent membrane (outline) of the erythrosensors and showing 
the least entrapment.  
 
 48 
 
 
 
Figure 15. Volume rendering sequence of FITC-glygly loaded erythrosensors. A. 3D-
image of FITC-glygly loaded bovine erythrocytes showing their spherical shape as 
the image is rotated on the x-axis. On the right a micrograph shows a single section 
of the z-stack. B Cropped z-stack of single erythrosensor sequential slice 1 through 
16 with a 0.40 µm step. On the right the relative cell fluorescence at each step. 
 
 
 49 
 
A representative movie of a Z-stack created using a step size of 0.40 µm to evaluate 
the loading uniformity of the population and of the FITC-glygly entrapment (Figure 15). 
Figure 15, presents the first image of the z-stack on the right, the sequential images were 
process to create the volumetric image and then rotated 90 degrees over the x-axis to reveal 
the distribution of FITC-glygly within the vesicle. It can be seen from the relative cell 
fluorescence graph that the erythrosensors are volume loaded, and the FITC-glygly is not 
just associated with the membrane. In fact, fluorescence is detected throughout the 
erythrosensors and shows that FITC-glygly is encapsulated within the erythrosensors. 
Interestingly, the 3D reconstruction animation of the z-stack fluorescent micrographs also 
revealed a spherical shape. 
 
Rat and bovine micrographs in figure 16show both types of erythrosensors loaded 
with FITC-glygly and their disk-like shape. Rat erythrosensors seem to entrap FITC-
glygly more uniformly than bovine according to the micrographs (Figure 16a). When the 
optical signal was evaluated, it was found that the rat erythrosensors had twice as much 
signal than bovine erythrosensors (Figure 16b). Rat and Bovine erythrosensors images 
were taken at different sections of the slide. This minimizes the possibility that the 
attenuation of the signal in bovine erythrosensors may be because FITC photo bleaches 
quickly. 
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Figure 16. Rat and bovine erythrosensors. Top confocal images comparing rat and 
bovine cells loaded via hypotonic dilution. Bottom relative cell fluorescence for each 
samples. 
 
 
The results obtained from the preliminary analysis of the erythrosensors 
morphology via confocal microscopy, showed a spherical shape (Figure 17). To further 
understand the changes in morphology, AFM was used to study the topography and the 
cross-section profile. The findings were compared with the resulting data collected from 
native erythrocytes as controls. 
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AFM results show a 40 μm x 40 μm scanning area and its corresponding 
topographical image (Figure 17). Control erythrocytes exhibit their characteristic shape 
and dimensions: disc shape with a 5-6 µm diameter and 1-2 µm heights, in accordance 
with normal diameter and height of erythrocytes in literature. The topographical image 
revealed the surface profile of erythrocytes (Figure 17). This 3D image shows the different 
stages of erythrocyte deformation. From this image, the biconcave morphology of normal 
native erythrocytes as well as erythrocytes with abnormal shapes (acanthocytes - spheroids 
and echinocytes - burr cells) can be observed. In a blood sample, it is normal to find such 
a population with cells at different stages of their life cycle. The abnormal erythrocytes 
found in this sample may be part of the aging population of erythrocytes in the sample, an 
artifact created by mishandling of the sample or by the test itself.  
 
 
 
Figure 17. AFM topographical profile of normal erythrocytes and erythrosensors 
Profile of normal erythrocytes (left) and erythrosensors (right). 
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 The erythrosensors imaged on Figure 17 reveals major morphological changes. 
The highest peak detected is on the erythrosensors topography is 875 nm. This peak does 
not account for the multiple valley, and irregular surface seen throughout the sample. 
Erythrosensors average diameter was irregular when compare to the normal diameter of 
native erythrocytes; the shape is circular, but flattened and only one third of the average 
height of a normal bovine erythrocyte (Figure 18-20). Figure 17 shows an example of the 
differing sizes and shapes found in a sample of erythrosensors. The average diameter for 
erythrosensors was found to be 4.48 µm, and the average height was 798.36 nm +/- 
421.243 standard deviation. This height average is about one half of the normal height for 
a native erythrocyte. However multiple hills and valleys are appreciated in the 
topographical images.  
 
 
 
Figure 18. Erythrosensors topography reveals hills and valleys in their surface. The 
heights of the erythrosensors shown in this images lies between 513-883 nm  
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Figure 19. Cross-section profile of normal bovine erythrocytes 
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Figure 20. Cross-section profile of erythrosensors. 
 
 
The roughness of the topography of the control erythrocytes and the erythrosensors 
exhibit differences in the topographical images, and upon quantification, the Ra value, 
which measure the deviation from the mean line and calculated using Bruker NanoScope 
analysis software. The Ra value was found to be greater in erythrosensors (Figure 21). The 
control erythrocytes have a normalized Ra value at 0.14 nm, while the Ra value for 
erythrosensors could be twice as the Ra value for control cells. In addition, the Ra value 
was found to be more variant for erythrosensors. 
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Figure 21. Ra value, measuring roughness of the surface. The mean of the absolute 
vertical deviation from mean line of the topographical profile. * P > 0.05 
 
 
Discussion 
Erythrocytes loaded via hypotonic dilution and electroporation maintained the disc 
shape needed to engineer successful erythrosensors. Abnormal shapes usually occur 
because of problems with the cytoskeleton or membrane, or secondary reasons including 
precipitation of hemoglobin. The cell flexibility is also dependent of the cell membrane, 
and the cytoskeleton. Factors affecting the yield, integrity and the performance of carrier 
erythrocytes include:  improper handling of cells, susceptibility to hemolysis, bio 
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distribution, in vivo stability and blood-borne diseases. Still, the ex-vivo artifacts of 
engineered carrier erythrocytes are not well understood and further optimization is 
required to minimize structural alterations and increase lifetime circulation.  
 
Loading erythrocytes using the hypotonic dilution method seems to achieve a more 
uniform/higher loading than loading erythrocytes with the same concentration of 
fluorescent dye using the electroporation method. Analysis of the absorbance at 540 nm, 
as a measurement of hemoglobin release, shows that the hypotonic dilution method causes 
the erythrocytes to lose more hemoglobin than the electroporation method. This study 
addressed the need to further understand and quantify changes to the erythrosensors by 
the process of encapsulation. 
 
It is imperative for the field, and necessary for the project, to evaluate efficiency 
of different protocols for loading erythrocytes. In addition, developing methods in 
accordance to with our aims (i.e. maintain intrinsic cell functions) is essential for the 
survival of the erythrosensors in-vivo and their sensing ability [11]. Our findings lay the 
basis for the characterization of encapsulation yields for Erythrocyte-based sensing. 
 
This study strived to further study changes in erythrosensors characteristics and to 
develop protocols for the characterization of the physical properties of erythrosensors. 
Cellular changes jeopardize the erythrosensors ability to circulate through poorly 
accessible capillaries. Characterization of erythrosensors loaded using the hypotonic 
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dilution included the evaluation of cell size, loading uniformity and morphology. 
Protocols to study the loading uniformity via confocal microscopy, and the cell 
morphology and topography using AFM were devised. Neither carrier erythrocytes nor 
erythrosensors’ cellular properties were well understood. Therefore, this study was step 
toward understanding the cellular properties of erythrosensors. 
 
The first question in this study sought to determine was the distribution of FITC-
glygly within the erythrosensors.  The results of this study showed that auto fluorescence 
was not related with the vesicles resulting from hypotonic dilution. One of the attributes 
of the erythrosensors loaded via hypotonic dilution is the emission of a strong fluorescent 
signal, which motivated the in-depth study of this loading technique. Different levels of 
fluorescence were detected from the erythrosensor population via hypotonic dilution, 
which suggests the need to further concentrate the loaded cells from the unloaded cells in 
the sample. Density separation by centrifugation was set as a standard for the study of 
erythrosensors via confocal microscopy and AFM. The resulting sample exhibits a 
concentration of erythrosensors with similar fluorescence. Although unloaded cells are 
also present in the sample. Concentrating erythrosensors with similar fluorescence 
increases the chances that, for example during AFM topographical images, the 
erythrosensors studied will be loaded with FITC-glygly. Another important finding was 
that loaded erythrosensors entrap the FITC-glygly within the vesicles instead of on the 
membrane. Before this study, the location of the fluorescence in carrier erythrocytes was 
not well characterized. Although past studies suggested encapsulation of FITC-glygly, 
 58 
 
there was not actually evidence of entrapment, until now. In addition to providing the 
volume within the erythrosensors where fluorescence is found, z-stack confocal 
micrographs also support the AFM results in terms of changes to the morphology.  
 
In the current study, the effect of the loading process on the Erythrocyte physical 
properties was assessed. Using AFM, the morphology, surface roughness and cross-
section profiles were evaluated. Decreased size, increased deformations, and rugged 
topography were some of the erythrosensor attributes found here. This study was unable 
to demonstrate erythrosensor mechanical changes because of the need to stabilize the 
vesicles via fixation. Bhraler et al. also found that carrier erythrocytes had a rugged cross-
section profile. The results presented in this thesis are consistent with Brahler et al. 
findings in which the cellular changes of carrier erythrocytes were first studied via AFM 
[66]. In addition, the surface roughness of erythrosensors, as measured by the Ra value 
(0.22 nm), is rougher than the surface of native erythrocytes (0.14 nm).  The study serves 
as motivation and a guide to continue the comparative investigation of the properties of 
erythrocytes and erythrosensors. 
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CHAPTER IV  
PRESWELLING ERYTHROSENSORS 
Extreme changes in osmotic conditions cause erythrocytes to hemolyse. It is well 
understood that pores form in the cell membrane as it equilibrates with the extracellular 
environment. This rearrangement of the cell membrane permits the entrance of exogenous 
molecules and hemoglobin efflux. Taking advantage of this reversible response, carrier 
erythrocytes have been studied to advance fundamental cell biology understanding, drug 
delivery and targeting, imaging enhancement and recently for biosensing applications.  
 
Senescent erythrocytes are cleared by organs of the reticuloendothelial system 
(RES). The loss of erythrocyte surface area leads to spherocytosis and subsequently to 
spleen entrapment [91] Previous studies of carrier erythrocytes have not dealt with their 
morphology and the role in their lifespan. In general, morphological changes lead to 
clearance signaling [92].  
 
Fluorescence-based assays used to study cell biological interactions, provide a 
measurement of features and/or activity. Erythrosensors could capitalize on erythrocytes’ 
cargo protection, and the navigation routes throughout the body, but as demonstrated in 
Chapter II the nature of the carrier erythrocytes (loaded with cargo) morphology remains 
unclear. 
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Ritter et al. studied a population of “ghost” erythrocytes non-uniformly-loaded 
with the pH-sensitive fluorescent dye FITC-glygly. The hypotonic dilution procedure was 
used. The findings included a population comprised 50-60% FITC-glygly-loaded resealed 
“ghost” erythrocytes and an entrapment (loading) efficiency ranging between 30-80% 
[13]. Moreover, loaded-erythrocytes tracked changes in extracellular pH. One issue was 
the resulting non-uniformly-loaded population of erythrosensors. In addition, 
erythrosensors must maintain physiological characteristics, and be compatible with near 
infrared dyes for in-vivo biosensing. 
 
The major drawback of the hypotonic dilution procedure include the considerable 
loss of hemoglobin (Figure 9) [85,93-95]. Ritter et. al. work required low hemoglobin 
erythrocyte carriers because FITC optical properties (excitation and broad emission 
spectrum peak wavelengths of 495 nm/519 nm) conflicted with hemoglobin (oxy and 
deoxy) absorption (540 nm). It is known that hemoglobin abnormalities contribute to 
morphological changes that lead to clearance from circulation [96-98]. Hence why carrier 
erythrocytes are commonly used for RES targeting. Changes to the erythrocytes 
physiology causes clearance from circulation. A desirable feature for RES targeted drug 
delivery but a limiting factor for long-term in vivo biosensing. 
 
Hypotonic preswelling is method develop by Rechsteiner which uses hypotonic 
conditions to drive the swelling to the lysis point [99]. It has been reported that this 
procedure causes minimal damage to the erythrocyte [41,100,101]. The procedure relies 
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on controlled swelling of the erythrocyte multiple times using a hypotonic buffered 
solution and an equilibration period (2-5 minutes) between each swelling step. The 
swelling is continued up to 150 mOsm/kg osmolality, the know point of lysis of 
erythrocytes. Depending on the protocol, the tonicity restoration was achieved with a NaCl 
or hypertonic solution for 60 mint at 40⁰C. The hypotonic preswelling has been use to 
load a number of drugs and calcein or FITC-BSA [99,102]. The controlled hypotonic 
environment, and the faster procedure are reported to contribute to the carrier erythrocytes 
having a lifespan like that of normal erythrocytes.  
 
Similarly, Erydel’s Cell Loader™ is an instrument designed by the Magnani group 
at University of Urbino, Italy to load red blood cells through sequential hypotonic buffer 
dilutions [53,103-109]. The Cell Loader™ has achiever 35-50% cell recovery and 
encapsulation efficiency of 30 %. Compared to the hypotonic dilution, with the Cell 
Loader™ five times more cells are recovered and the efficiency stands comparable.  
 
Loading via the hypotonic dilution procedure, erythrocytes are subjected to an 
abrupt osmotic pressure change to achieve lysis of the cell membrane. While hypotonic 
preswelling is based on control swelling of the erythrocyte to the lysis point. Along these 
lines, inducing a control osmotic change to gradually swell and drive pore formation is 
desired to maintain physiological morphology. In addition to minimizing structural 
changes, increasing the fluorescence signal on cell-by-cell basis, and achieving loading 
uniformity is also critical to the practical application of erythrosensors. These goals led to 
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formulation of a protocol to load carrier erythrocytes with fluorescent sensors which 
conserve the intrinsic characteristics of erythrocytes. To prevent biofouling, and clearance 
by the RES, erythrosensors must mimic naive erythrocytes. 
 
A simpler and faster swelling-based loading procedure was developed based on 
the preswelling procedure and hypotonic dilution (Figure 22). This method avoids 
complicated tools such as those used by the Cell Loader™. The key feature of the 
technique is controlling the osmolality depending on the size of the cargo molecule to 
achieve high hemoglobin, increased erythrosensors recovery, and uniform loading. Under 
appropriate condition this highly controllable, adaptable and scalable procedure efficiently 
loads erythrocytes while maintaining the innate erythrocyte morphology. Futuristically, 
we aim to incorporate a glucose fluorescent sensor. We aimed to improve survivability by 
taking into consideration the morphology and the hemoglobin needed to maintain 
physiological features and function.  
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Figure 22. Preswelling vs hypotonic dilution procedure. 
 
 
Erythrocytes from different species exhibit not only different surface antigens, but 
also differ in size, shape, and life-span. In terms of size, for example, rats’ erythrocytes 
have an average 6.5 µm diameter human erythrocytes’ diameter lies around 7.2 µm while 
bovine erythrocytes have a 5.8 µm diameter. Rats, bovine and human erythrocytes have a 
life span of 60, 160 and 120 days respectively. Erythrocytes from different species have 
different properties, however, the loading concept can be tailor across species. 
Erythrosensors derived from bovine erythrocytes were used to understand the 
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physiological properties, and ultimately hoping to tailor erythrosensors to specific 
fluorescent sensors, analytes, and targets.  
 
Image Stream allows for simultaneous characterization of the size, shape and 
fluorescent signal in a per cell basis. This tool produces quantitative data of the features 
of a larger number of cells [92]. In this study, we characterized the percentage of recovered 
cells after loading, and the dimensional parameters such as the area, length. To analyze 
the morphology of the resulting erythrosensors, the aspect ratio and circularity were 
evaluated. Finally, the in-vitro relative level of fluorescence per cell was studied using the 
intensity feature.  
 
Aiming to implement the erythrosensors into ophthalmological applications, the 
loading efficiency and hemoglobin levels were studied using ICG and FITC-glygly. The 
FDA approved dye idocyanine green (ICG) was studied for retinal imaging. ICG is 
routinely used in medical diagnostics particularly angiographies. It has an absorption peak 
at around 750-950 nm and an emission peak 810-830 nm [110,111]. The infra-red range 
permits deeper imaging than using fluorescein. It has a half-life of up to 180 seconds and 
is remove by the liver from circulation.  
 
Results 
Cells images were collected using image stream. After cell preparation, cells were 
washed in PBS and suspended at 50% hct. Samples were maintained in ice at 4˚C prior to 
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final dilution and collection. To maintain the cell morphology, cells were diluted in 1% 
BSA-PBS at 1:10 (V/V). Images were collected using defined parameters: 20X 
magnification and standard 488 nm laser at 20mW power to excite FITC. For the 
collection of images from the erythrocytes loaded via hypotonic dilution, 80,000-100,000 
events were collected to ensure sufficient sample for analysis.  A maximum of 20,000 
events from triplicates for each sample were collected. The data exploration (IDEAS v.4) 
software package was used for analysis of the dimensional, morphological, and 
fluorescent features of the cell images. 
 
Five different erythrocyte treatments were evaluated per experiment: one native, 
two controls (Preswelling without cargo and native erythrocytes mixed with cargo) and 
two experimental samples (Preswelling with cargo FITC-glygly and hypotonic dilution 
with cargo FITC-glygly). Native erythrocytes were used to compare size and shape, 
confirming that the dimensions or morphology have not change due to non-specific 
artefact during process and data collection. As a control to ensure that fluorescence is not 
due to cell auto fluorescence, erythrocytes were subjected to the preswelling treatment 
without any fluorescent cargo present. Native cells mixed with FITC-glygly were also 
evaluated to evaluate spontaneous uptake/association of the FITC-glygly with the 
erythrocyte membrane. 
 
To evaluate the performance of the image flow cytometer the native erythrocytes 
and preswelling erythrosensors without cargo were first evaluated. The control cells 
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without FITC-glygly were run second, followed by the samples containing FITC-glygly 
in the process. Subsequently, FITC-glygly loaded erythrosensors produced via 
preswelling and hypotonic dilution were assessed. The erythrocytes and erythrosensors 
samples were suspended in 1% BSA PBS. This scheme also prevented accidental cross-
contamination between samples. 
 
Three data channels were used for the acquisition of image stream data. Channel 
1 collected the calibration beads used to calibrate the instrument. Channel 5 captured a 
bright field image and channel 3 captured a fluorescence image. Cell classifier settings 
were used to collect the population of interest and ignore cell beads and debris.  
 
To define the region of interest (mask) in the images of the gated population, two 
different templates were created. The first template was used for the native erythrocytes, 
the control and the preselling erythrosensors samples. The mask was defined using the 
bright field channel images and plotting the area in the x-axis and the aspect ratio in the 
y-axis to identify image with single cells. The second template was used for the hypotonic 
dilution erythrosensors. Due to low hemoglobin, the hypotonic dilution samples exhibited 
low contrast in the bright field channel. Thus, for the hypotonic dilution samples, the 
fluorescence channel was used to define the mask.  
 
The population of single cells was defined by gating cells “face on” and 
“sideways” in the native erythrocytes sample and applied to both the control, preswelling 
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and hypotonic dilution erythrosensors. The gated region is shown in blue on figure 24. 
Building from the single cell population (blue gate), the images in focus were selected 
after analyzing the contrast and the gradient rms (root mean square of the rate of change 
of the image intensity profile) features. These features use the intensity variation in images 
to measure the sharpness of an image. Both detects large changes in pixel value but 
assigned different weighted values to the pixel. But, while contrast doesn’t subtract the 
background, gradient rms does. Subsequently the dimensions of the defined population 
(face on and sideways) were measured using the area and length features; the shape 
definitions were obtained using the aspect ratio, compactness, and circularity; the signal 
strength was measured with the intensity feature. 
 
 
 
Figure 23. Example of discrimination of erythrocytes based on position captured. 
Left shows erythrocyte “face on” and right shows erythrocyte “sideways” as detected 
on control samples.  
 
 
The area and length of the different samples were evaluated. The area feature on 
the x-axis is shown in µm and it is calculated by converting the number of pixels of the 
mask region in the image to area (1 pixel =0.25 µm2). The length feature was used to 
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analyze the longest dimension of each cell. This was critical for comparison and to 
measure the diameter accurately while accounting for erythrocytes biconcave shape and 
the different cell orientations in the images (Figure 23). 
 
 
 
Figure 24. Example of analysis template. Top: Control and preswelling sample of 
template. Bottom: Sample template for hypotonic dilution population.  
 
 
First the single cells which fall within the area and aspect ratio intensity parameters 
used for the control native erythrocytes were defined (Figure 24 top). The approximate 
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area expected for a “face on” cell with a diameter between 4 and 8 µm was calculated to 
be between 10 and 51 µm2. However, to capture erythrocytes and erythrosensor 
abnormalities, an area region between 10 and 100 µm was used for all the samples. An 
aspect ratio intensity value between 0.9-1 indicates roundness of the fluorescent image. 
However, because of the biconcave shape of native erythrocytes the aspect ratio intensity 
can be lower. For the “face on” a cut out of 0.7 was determined. For the “sideways” 
samples the limitation for the gate were set between 0.5 and 0.7 was used.  
 
The initial native erythrocytes scatter plot (Figure 24 top) revealed a population of 
interest concentrated between 10-100 in the area and 0.5-1 in the aspect ratio intensity. 
The population in the control and preswelling samples showed events facing front labeled 
“face on” lie between 0.7-1 in the aspect ratio side. While the events facing sideways lie 
between 0.5-0.7 in the aspect ratio side.  The distribution of the population in the hypotonic 
dilution plot is seen clustered (Figure 24 bottom). Populations are indistinguishable one 
from another.  
 
In addition, the native erythrocytes, control and the preswelling sample exhibited 
two populations. Table 2 shows that between 7-10% of events were capture in a 
“sideways” position and between 71-73% of events were captured in a “facing on” 
position. Remarkably different to the undetected “sideways” position and 25% “face on” 
orientation of the hypotonic dilution events. 
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Table 2. Samples and percentage of cells in face on and sideways positions 
 
Sample Cargo Face On Sideways 
Control Naive No Cargo 72% 8% 
Control Preswelling No Cargo 71% 7% 
Control Native + FITC FITC-glygly 73% 10% 
Preswelling FITC-glygly 76% 9% 
Hypotonic Dilution FITC-glygly 25% None 
 
 
Histograms were used to evaluate the population on interest dimensions, 
morphology and fluorescence signal intensity. The results corroborated the two 
orientations findings for the erythrocytes with biconcave shape, face on and sideways. 
Thus, the histogram shows the events orientation as follows: “sideways” orientation in 
gray while the “face on” orientation are shown in red for the following graphs.  
 
The area and length features were used to evaluate the dimensions of the samples. 
The population distribution and the average for the area and length features were different 
between the native erythrocytes, and control samples, and the hypotonic dilution 
erythrosensors. However, the native erythrocytes, control and preswelling samples 
exhibited similarities in the two populations distribution found (“sideways” and “face on”) 
and in area and length of the events. The native erythrocytes face on sample had an area 
of 28.21 µm2 +/-7.96. The hypotonic dilution erythrosensors exhibited an area average of 
9.55 µm2 +/-13.95, while the average area for preswelling erythrosensors facing on was 
28.35 µm2 +/- 7.78. The hypotonic dilution shows greater variability and a bimodal 
population distributed up to 100 µm2 in terms of the area (Figure 24). With respect to the 
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length the events in the hypotonic dilution correlates with normal bovine diameter 
(approx. 5.8 µm) and the previous work that showed a normal diameter in hypotonic 
dilution erythrosensors. For the control, native erythrocytes face on and sideways the 
average length was 5.98 µm +/- 0.9185 and 5.470 µm +/- 0.6189 respectively. The 
hypotonic dilution erythrosensors exhibited a length averaging of 5.764 µm +/-1.479 while 
the preswelling erythrosensors show an average length for face on and sideways of 5.98 
µm +/- 0.8959 and 5.425 µm +/- 0.6103. Throughout the flow cytometry work the 
sideways population present in control native erythrocytes and preswelling is absent in the 
hypotonic dilution analysis. Since the hypotonic dilution erythrosensors acquire a 
spherical shape (chapter III), this morphological change could explain why a sideways 
population is not recognizable.  
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Figure 25. Dimensions of native erythrocytes, controls and erythrosensors. Control 
samples include native erythrocytes, preswelling erythrosensors without any FICT-
glygly and native erythrocytes mixed with FITC-glygly having undergone a loading 
procedure. Preswelling and hypotonic dilution erythrosensors with FITC-glygly as 
cargo were also analyzed.  
 
 
 Erythrocyte distinguished from other cells by their enucleation and biconcave 
morphology. These unique features contribute significantly to their mobility and function. 
The aspect ratio, compactness and circularity features were used to identify potential 
changes in these characteristics.  
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The aspect ratio (length to width ratio) is a feature use to detect elongation or 
roundness of the event by dividing the minor axis and the major axis. Thus, it was used to 
discriminate between single (equal width and height) and double events in an image and 
to determine the shape of the samples. The controls show 65% of events have an aspect 
ratio close to 1.0, indicating mainly rounded events in the cells “face on”. Native 
erythrocytes mixed with FITC-glygly and the preswelling erythrosensors with cargo 
FITC-glygly presented a left shift towards 0.8. The histogram for “sideways” events in the 
control and preswelling, the histogram shows a left shift towards 0.7 that correlates with 
the elongated shape of the erythrocyte shape when oriented sideways. The preswelling 
loaded with FITC-glygly had increased frequency of events between 0.8-1.0, indicating 
more events with a rounded shape. However, there is a tail in the “facing on” cells below 
0.8. The hypotonic dilution exhibits a tail in the graph that extends even more than the tail 
on the preswelling samples reaching up to 0.6 in the aspect ratio histogram.  
 
 To evaluate and compare the morphology of the samples, the compactness and 
circularity features were used. These features were used to identify non-circular events in 
the dot plot. The circularity feature measures the deviation from the image and the mask 
of a circle (how much the radius varies). Rounder events have low radial variance and a 
high circular score. The feature scores the events between 0 and 30, the higher the value, 
the closer the shape is to a circle. If the shape deviates from a circle, is found to be ruffled 
or elongated, the circularity score will be low (high radial variance). The compactness, 
measuring the compression, the higher the value the more condensed is the event. In terms 
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of circularity, the control samples and the preswelling had an average 10.85 +/- 2.67 and 
10.98 +/- 2.64 score, respectively. The hypotonic dilution shows drastic differences with 
a 6.94 +/- 4.81 score. The hypotonic dilution samples exhibited a lower circularity value 
and more variation, which indicates irregularities in the shape. 
 
 
Figure 26. Morphology of native erythrocytes, controls and erythrosensors. Samples 
was determined by the aspect ratio and circularity. 
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Figure 27. Fluorescence signal strength in erythrosensors. Erythrocytes were loaded 
via preswelling and hypotonic dilution.  
 
 
The intensity feature use to evaluate the fluorescence signal strength for the 
samples subtracts the average background pixel value from the area of interest (Figure 27 
and Figure 28). As expected the controls without FITC-glygly the sample had no 
fluorescence signal. Confirming that the fluorescence signal is not product of auto-
fluorescence or other non-specific reactions. On one hand, the hypotonic dilution, just as 
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seen before, exhibits variability in the fluorescent signal with an average intensity of 1386 
+/- 2200.46. In fact, three peak are evident in the histogram. On the other hand, the 
preswelling with FITC-glygly technique shows a single peak with a 4-fold increase in the 
signal with an average intensity of 6577.68 +/-2034.78. One-way ANOVA revealed 
significant difference among all the samples except the control naïve and the preswelling 
without FITC which had no significant difference. The error bar represents the standard 
deviation P<0.0001. A striking finding was the control naïve erythrocytes mixed with 
FITC-glygly procedure showed fluorescent signal in the events and even a shift towards a 
stronger fluorescent signal with an average intensity of 6704.94 +/-1114.11. 
 
 
 
Figure 28. Summary of average intensities in samples. The populations face on and 
sideways were used for the overall average.  
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Subsequently, the bright field and fluorescent images of the samples were 
examined to understand the evidence of the florescence signal detected in the native 
erythrocytes mixed with FITC-glygly without having undergone a loading procedure 
(Figure 29). The naive erythrocytes mixed with FITC-glygly exhibit similar morphology 
to the native erythrocytes. However, the fluorescence signal seems irregular and 
superficial when compared to the preswelling loaded with FITC-glygly. If we now turn to 
the hypotonic dilution sample, the three differing populations in the sample can be 
identified in the images. Furthermore, the misshapen and low contrast events in the bright 
field and the fluorescence values variability in the intensity were upheld. The preswelling 
with and without FITC-glygly exhibit similar morphology and size. In fact, the 
fluorescence in channel 3 appears to be the only difference. The preswelling sample loaded 
with FITC-glygly also shows a uniform loading. To further characterize the results from 
the naïve erythrocytes mixed with FITC-glygly without having undergone a loading 
procedure, the reactivity of FITC and FITC-glygly with naïve erythrocytes was 
investigated.  
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Figure 29. Examples of image file data for each sample condition. Channel 3 show 
the fluorescence image and channel 5 shows the corresponding bright field image. 
 
 
 
 Naïve erythrocytes mixed with FITC-glygly exhibited a shift towards greater 
signal strength. This raised the question as to whether this is due to spontaneous loading 
(endocytosis), or non-specific interactions with the membrane. To answer this question, 
naïve erythrocytes were mixed with different FITC-glygly and FITC only formulations. 
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 FITC can react with amine groups on proteins. Results from control naïve 
erythrocytes mixed with FITC and FITC-glygly show that when FITC is mixed with 
erythrocytes it can lead to reactivity with the cells which exhibit a strong fluorescent 
signal. We investigated at FITC-glygly diluted in dH2O or PBS mixed with naïve 
erythrocytes and found there was no increase in the fluorescence signal ( 
Figure 30). Indicating the possibility that the control with FITC-glygly must have 
unreacted FITC, leading to non-specific association with membrane proteins and, thus, a 
strong signal in the naïve erythrocytes mixed with FITC-glygly. A representative 
maximum intensity projection and Z-Stack of naïve erythrocytes mixed with FITC is 
shown in figure (Figure 30). Bovine erythrocytes were used to create a z-stack with step 
size between images shown of 1 microns. 
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Figure 30. FITC reactivity with erythrocytes. A. naive erythrocytes mixed with 
FITC-glygly diluted in PBS or dH2O, and FITC only were mixed with native 
erythrocytes. FITC-glygly reaction was incubated for 2 hours instead of 30 minutes. 
B. Unconjugated FITC interaction with erythrocytes shown in z-stack with 1 m 
step. C. Confocal images showing erythrosensor loaded with FITC-glygly produced 
via the preswelling technique on the left and the native erythrocytes mixed with just 
FITC.  
 
 
The initial investigation aimed to determine if this newly developed method could, 
in fact, load erythrocytes with fluorescent dye while maintaining innate morphology. The 
features derived from the individual Image stream data for each condition: controls: naïve, 
naïve with FITC-glygly and preswelling without FITC-glygly, and the preswelling with 
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FITC-glygly, were used to construct the principal component analysis (PCA) to achieve 
an objective statistical method to differentiate between the groups. The parameters 
analyzed were the area, aspect ratio, circularity, compactness and intensity. The four 
conditions were plotted, defined by the 1st and 2nd principal component functions. PCA 
reduces the data dimensions for visualization in a two-dimensional plot (Figure 31). In the 
figure, blue represents the naïve erythrocytes (Naïve), red shows the preswelling loading 
using with FITC (Preswelling), green shows the preswelling without FITC (PreNoFITC) 
and maroon represents the naïve erythrocytes mixed with FITC-glygly (NF).The results 
show the samples without FITC-glygly locate in the same region in the plot, indicating 
that the preswelling without FITC-glygly and the naïve erythrocytes compare and the 
loading procedure does not alter the parameters analyzed. Preswelling without FITC-
glygly and naïve erythrocytes with FITC-glygly exhibit the same characteristics in terms 
of the variables evaluated (dimension, morphology). The preswelling loading using FITC-
glygly groups in a specific form indicating that the fluorescence is a factor that can be 
utilized to differentiate the samples. Once the fluorescence in analyzed the population 
shifts to the right and aligning the fluorescent samples in the same region. The aggrupation 
of the samples with and without FITC-glygly is seen.  
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Figure 31. Principal component analysis (PCA). The multiparameters analysis was 
used on naïve/without FITC, and preswelling with/without FITC samples. The 
color of the symbols represent: ○ naïve erythrocytes, ○ preswelling treatment no 
FITC, ○ naïve erythrocytes mixed with FITC-glygly, ○ Preswelling treatment 
loaded with FITC. 
 
 
To visualize preswelling erythrosensors confocal imaging was used to confirm 
morphology and fluorescent signal. A representative image of erythrosensors is shown in 
Figure 32. The confocal imaging was collected immediately after loading procedure. The 
erythrosensors seems to mimic the control erythrocytes size. FITC-glygly loading is 
shown in green color. Overlays of the transmission and fluorescence channels are shown 
in the right.  
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Figure 32. Confocal imaging reveals uniform loading and shape of erythrosensors. 
Volumetric analysis of bovine erythrocytes loaded via preswelling revealed 
volume-loading through the erythrosensors (Figure 33). An example of a maximum 
intensity projection and the region selected for further analysis is shown in the yellow 
square in the top image. The Z-stack is shown with a size of 1 micron. The fluorescence 
image shows the cells were loaded with FITC-glygly. 
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Figure 33. Maximum intensity projection and z-stack of bovine erythrosensor.  
 
 
Looking at the hemoglobin retained and comparing with the hemoglobin levels 
achieved with other loading procedures, the mean concentration between erythrosensors 
loaded via preswelling and the control erythrocytes is comparable (Figure 34). As seen in 
Chapter III, hypotonic dilution erythrocytes retained only 11% of hemoglobin 
concentration, while electroporation retained 60% of hemoglobin. In addition, the 
measured hemoglobin concentration of 8.99 g/dL +/- 0.655 matches the concentration of 
normal bovine erythrocytes. This will help the erythrosensors mimic erythrocyte 
characteristics and functions while functionalized as a sensor carrier.  
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Figure 34. Hemoglobin retained in erythrosensors loaded via preswelling. 
 
 
 Strong evidence of successful loading via the preswelling technique led us to 
attempt loading human erythrocytes. The yellow box in the maximum intensity projection 
shows the erythrosensors studied (Figure 35). The procedure was tailored to human 
erythrocytes for loading FITC-glygly cargo. The resulting data shows volume loaded 
erythrosensors with an average area of 55.26 +/- 14.06 and an average diameter of 8.906 
+/- 1.063. Normal human erythrocytes are reported to have a diameter between 6-8 
microns. These results give the first glimpse of how the developed technique can be 
tailored to load erythrocytes from different species, while maintaining the characteristics 
critical for prolonged in-vivo survival. 
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Figure 35. Preswelling procedure on human erythrocytes. Top image shows the 
maximum intensity projection and the yellow box indicates z-stack pictured in the 
bottom with a step size of 1 µm. 
 
 
 Loading of an NIR dye using the preswelling technique was evaluated. 
Indocyanine green (ICG) is an FDA approved dye commonly used in diagnostic 
applications. Structurally ICG is a larger molecule than FITC, with infrared absorbing 
properties (800 nm) and little absorption in the visible range. It is an NIR dye with 
applications ranging from imaging-guided photo thermal therapy, contrasting agent for 
angiography [109-1110].  
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To tailor the preswelling procedure to load a molecule larger than the model cargo 
FITC-glygly into human erythrocytes, different osmolarity conditions were evaluated, and 
a standard curve was constructed. The implementation of ICG as a model cargo was 
limited by the lack of an infra-red detection system on the microscope. Naive erythrocytes, 
erythrosensors created via preswelling loaded with ICG and a control sample which 
underwent preswelling procedure without ICG were evaluated using spectrophotometric 
analysis. At the end of the procedure the supernatant was also saved. After several sample 
washes, erythrosensor entrapment of ICG was evaluated by cellular rupture in deionized 
water. The supernatant for each experimental sample after the procedure was also 
analyzed to validate with results for cargo entrapment. For an initial concentration of 20 
µg ICG per 1 ml of human erythrocytes, an entrapment efficiency (the percent of cargo 
entrapped into erythrosensors) of 48.5% was found. 
 
 
Figure 36. Adapting preswelling procedure to NIR dye ICG. 
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Discussion 
Erythrocyte pathological abnormalities (dimensional and morphological) have 
been extensively investigated. Safeuki et al. (2012) use image flow cytometry to show 
splenic entrapment of erythrocytes with changes in these features [91,112]. Motivated by 
these findings, the size, morphology and fluorescence signal of erythrosensors were 
evaluated. Prior studies noted the importance of maintaining hemoglobin levels, to 
conserve the characteristics that make erythrocytes attractive sensor carriers [13,14]. 
A strong relationship between size/morphology and the survival of erythrocytes 
has been reported in literature [112]. The current study’s findings correlate with our 
previous results showing the abnormal morphology that the hypotonic dilution procedure 
causes to the erythrocytes. While the erythrosensors maintain a size in the region of normal 
erythrocytes, the biconcave shape alters to a spherical form. Thus, we aim to develop a 
procedure that maintains the size and shape of normal erythrocytes. 
Based on previous work where reverse osmosis is used to load erythrocytes, we 
developed a rapid technique to gently load fluorescent dye. Using the preswelling loading 
procedure we improve hemoglobin retention and homogeneity of loading of FITC-glygly. 
The size and shape of erythrosensors matched well with the measurements of normal 
erythrocytes. In addition, the narrow fluorescent signal exhibited a 3-fold increase over 
the hypotonic dilution. 
 89 
 
Surface coating of erythrocytes with fluorescent molecules have been well studied 
to answer biological questions, and understand erythrocytes’ properties. Although the 
erythrocyte membrane is considered a semipermeable membrane, it is highly selective. 
Through osmosis, a solvent such as dH2O diffuses into a more concentrated solution to 
reach equilibrium in the concentration of solutes. In erythrocytes subjected to a hypotonic 
solution, water diffusing out may account for the preswelling procedure functioning to 
load erythrocytes with cargo while causing minimal changes. 
 
The high affinity for proteins and pH response makes FITC an ideal compound to 
investigate the extracellular pH tracking. However, these characteristics also present 
issues of non-specificity association of reactant FITC with membrane proteins. These 
properties may explain the control naïve exhibiting a strong fluorescent signal when mixed 
with FITC-glygly –and potentially unreacted FITC. In the past, FITC has routinely been 
conjugated with glycylglycine, however, the FITC-glygly conjugation process was not 
followed by further purification for removal of unreacted FITC. FITC is a charged 
molecule. FITC-glygly conjugation leads to net negative charges resulting in background 
and non-specific binding to positive surfaces. Unbound FITC should be removed by a 
suitable purification method such as gel filtration. Also, blocking with 1% BSA PBS (1% 
bovine serum albumin diluted in 1X PBS) the membrane protein could prevent non-
specific interactions. Other FITC characteristics that may hinder the analysis include: 
collisional quenching of fluorescence, photo bleaching, and quenching in acidic conditions 
and instability in water (subsequently aqueous media). 
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The most interesting finding was the highly controllable, adaptable and scalable 
procedure to load erythrosensors with fluorescent cargo. We successfully loaded FITC-
glygly into human erythrocytes. These loaded erythrocytes exhibited similar 
characteristics to normal erythrocytes and bovine erythrocytes loaded with FITC-glygly 
using the preswelling technique. 
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CHAPTER V 
SUMMARY, LIMITATIONS AND OUTLOOK 
Using erythrocytes as sensor carriers, we explored their dimensions and 
morphology as well as the biological features required for long term monitoring. In chapter 
II, loading procedures were optimized around encapsulation of FITC-glygly in 
erythrocytes. Erythrosensors loaded via hypotonic dilution and electroporation lost 89% 
and 46% of the total hemoglobin, respectively. In terms of fluorescence, erythrosensors 
loaded via hypotonic dilution had 4X more fluorescence intensity than cells loaded using 
electroporation. The results of these studies suggest that hemoglobin levels and cargo 
loading concentrations are inversely related using these techniques. These findings are 
particularly useful as the basis to standardize the characterization erythrosensors used in 
an erythrocyte-based sensing system. 
 
Since the overall goal of this work was to study FITC-glygly loaded erythrocytes 
and hypotonic dilution was shown to have the most fluorescence per cell, the work in 
chapter III focused on providing deeper insight into cellular changes in erythrosensors 
loaded via hypotonic dilution. Initially, the capacity of erythrosensors to entrap the optical 
sensor dye was demonstrated in both rat and bovine erythrocytes. Micrographs of the 
resulting population showed erythrosensors with varying levels of FITC-glygly 
encapsulated and 3D images render insight into erythrosensor shape.  
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From the fluorescent images, it was apparent that the cell underwent both, 
morphological and topological changes. The use of AFM to characterize erythrosensors 
provided a route to explore these changes. Erythrosensors loaded via hypotonic dilution 
shrink, and their surface topography became rugged. Until now, the morphological 
changes erythrosensors underwent when subjected to the hypotonic loading procedures 
were unknown. The results showed that the height, and diameter size of the cell decreased. 
Native erythrocytes were found to have a 5-6 µm diameter range and 1-2 µm height range. 
FITC-glygly loaded erythrosensor height and diameter size were found to have decreased 
by an average of 1 µm in both diameter and height. Furthermore, the surface of 
erythrosensors was found to be up to twice as rough as the surface of native erythrocytes. 
After verifying erythrosensors integrity via AFM, it was confirmed that erythrosensors 
loaded via hypotonic dilution lost standard erythrocyte architecture. The erythrosensor 
cellular characteristics found in this study, could limit their ability to circulate through 
small capillaries, obstruct oxygen transportation and lead to rapid clearance. 
 
Reschsteiner and Tsang et al. first showed erythrocyte preswelling procedures 
loading Calcein or FITC-BSA as cargo and exploring successive swelling with 
equilibration periods (2-5 min) followed by restoration of its tonicity with a NaCl solution 
for 60 min at 40˚ C [99,102]. Inspired by the simplicity of the preswelling procedure, a 
rapid procedure was developed, considering recent clinical finding to conserve the 
characteristics of the erythrocyte. In addition, loading of FITC-glygly and NIR dye, such 
as ICG in human erythrocytes was demonstrated. The results showed that the method 
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chosen for erythrosensor production will have a critical impact on the sensor carrier ability 
to mimic normal erythrocytes.  
 
Limitations 
There are a number of questions unanswered. For example, how does FITC 
concentration loading affect hemoglobin concentration and loading efficiency using the 
preswelling technique? Another question is how the oxygen transportation function is 
affected by the procedure? The location (external, internal, or transmembrane association) 
of the sensing probes could also affect the overall functionality.  
 
Other erythrocytes biological characterization should also be considered to 
improve the effectiveness of erythrocytes as erythrosensors. Well-studied erythrocyte 
features such as the membrane composition and the integrity should be analyzed. In 
addition, new strategies to load erythrocytes and verify the integrity of the resulting 
erythrosensors in physiological conditions should be explored and evaluated using the 
methods developed here.  
 
Outlook 
A blood sample could provide the autologous erythrocytes essential to the long 
term blood analyte monitoring system erythrosensors. Although blood samples are easy 
to collect, there are drawbacks for patients such as, diabetics:  pain, and scarring tissue 
could lead to inflammation and other complications. This study of a minimally invasive 
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platform for measurements of blood molecules such as glucose was advanced. Common 
erythrocytes loading procedures were evaluated and an alternative loading procedure were 
advanced. However, there is also an opportunity to investigate loading of circulating 
erythrocytes in-vivo, without having to take the invasive blood sampling. 
 
Every second erythrocytes are destroyed in the RES. Although erythrocytes are 
abundant, it is worthwhile to investigate loading of other populations of cells such a 
lymphocyte to detect, not only analytes of interest but maladies biomarkers. This approach 
can be used for monitoring of progression, and or management of diseases that are 
currently managed via blood sampling.  
 
The cell morphology of erythrocytes has been attributed to the need to transport 
oxygen, giving erythrocytes more area while being able to squeeze through capillaries. 
Thus, maintaining the morphology is not only critical to guaranteeing prolonged survival, 
but it could also be potentially beneficial to maximize the area and the transportation of 
the cargo, in this case FITC-glygly. In addition, it is essential to achieve the maximum 
concentration per cell to translate it into circulatory signal emission. 
 
Erythrocytes respond to osmolarity changes and a number of probes for sensors 
can be entrapped during the intracellular equilibration period. Carrier erythrocytes have 
been used for the treatment of adenosine deaminases (ADA) deficiency, which causes 
immunodeficiency. Potential toxicity and immune response is reduced when using carrier 
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erythrocytes encapsulating ADA therapy compared to the bolus dye systemic 
administration in the blood stream. Biocompatibility, biodegradability, and low toxicity 
makes erythrocytes attractive for use as a drug transportation system. Thus, these 
protective features are also sought after in the implementation of carrier erythrocytes for 
biosensing applications. Erythrocytes carriers and erythrosensors can encapsulate 
different molecules, and they offer cargo protection. 
 
In the future, preswelling erythrosensors’ ability to sense glucose while 
maintaining native cellular and mechanical properties, should be evaluated. Confocal 
microscopy and AFM have been used to study erythrocytes extensively. In this thesis, I 
developed protocols to characterize erythrosensors. Despite its exploratory nature, this 
study offers insight into standardizing methodologies to assess carrier erythrocytes and 
erythrosensors cellular features.  
 
A limiting factor with fragile biological samples, such as erythrocytes, is the 
storage limitations which also impacts the ability to implement in clinical practice. 
Maintaining the physiological characteristics, as well as the fluorescence signal is critical 
for the study and clinical application of erythrosensors.  
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